Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Inflamm Bowel Dis

Retrieve available abstracts of 654 articles:
HTML format



Single Articles


    November 2022
  1. WONG ECL, Dulai PS, Marshall JK, Jairath V, et al
    Predictors of Clinical Remission to Placebo in Clinical Trials of Crohn's Disease.
    Inflamm Bowel Dis. 2022 Nov 25:izac231. doi: 10.1093.
    PubMed     Abstract available


  2. CHEN K, Chen J, Smith E, Mathani P, et al
    Serum Ustekinumab Concentrations Are Associated With Improved Outcomes With the Magnetic Resonance Index of Activity for Crohn's Disease.
    Inflamm Bowel Dis. 2022 Nov 24:izac236. doi: 10.1093.
    PubMed    


  3. COLMAN RJ, Samuels A, Mizuno T, Punt N, et al
    Model-informed Precision Dosing for Biologics Is Now Available at the Bedside for Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Nov 22:izac237. doi: 10.1093.
    PubMed    



  4. Correction to: Occurrence and Clinical Impact of Eosinophilic Esophagitis in a Large Cohort of Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Nov 18. pii: 6832530. doi: 10.1093.
    PubMed    


  5. POLAT G, Kani HT, Ergenc I, Ozen Alahdab Y, et al
    Improving the Computer-Aided Estimation of Ulcerative Colitis Severity According to Mayo Endoscopic Score by Using Regression-Based Deep Learning.
    Inflamm Bowel Dis. 2022 Nov 16. pii: 6830946. doi: 10.1093.
    PubMed     Abstract available


  6. YOGEV D, Verstockt B, Dignass A, Focht G, et al
    The Modified Mucosal Inflammation Noninvasive Index and Endoscopic Remission in Adults With Crohn's Disease.
    Inflamm Bowel Dis. 2022 Nov 9:izac235. doi: 10.1093.
    PubMed    


  7. LICHTENSTEIN GR, Bressler B, Francisconi C, Vermeire S, et al
    Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program.
    Inflamm Bowel Dis. 2022 Nov 7. pii: 6808367. doi: 10.1093.
    PubMed     Abstract available


  8. SHIMOYAMA T, Yamamoto T, Yoshiyama S, Nishikawa R, et al
    Leucine-Rich Alpha-2 Glycoprotein Is a Reliable Serum Biomarker for Evaluating Clinical and Endoscopic Disease Activity in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Nov 5. pii: 6804445. doi: 10.1093.
    PubMed     Abstract available


  9. RAMOS L, Hernandez-Porto M, Carrillo-Palau M, Alonso-Abreu I, et al
    Impact of Biologic Agents on the Immune Response Induced by the Additional Dose of SARS-CoV-2 Vaccine in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2022 Nov 2. pii: 6793895. doi: 10.1093.
    PubMed    


  10. SCHWEDA A, Becker E, Wiendl M, Atreya R, et al
    Etrolizumab-s Does Not Induce Residual Trafficking of Regulatory T Cells.
    Inflamm Bowel Dis. 2022;28:1746-1755.
    PubMed     Abstract available


  11. DALAL RS, Bains K, Marcus J, McClure EL, et al
    Tofacitinib for the Treatment of Pouch-Related Disorders: A Case Series.
    Inflamm Bowel Dis. 2022;28:1787-1789.
    PubMed    


  12. KREISS L, Thoma OM, Lemire S, Lechner K, et al
    Label-Free Characterization and Quantification of Mucosal Inflammation in Common Murine Colitis Models With Multiphoton Imaging.
    Inflamm Bowel Dis. 2022;28:1637-1646.
    PubMed     Abstract available


  13. XU L, Huang G, Cong Y, Yu Y, et al
    Sex-related Differences in Inflammatory Bowel Diseases: The Potential Role of Sex Hormones.
    Inflamm Bowel Dis. 2022;28:1766-1775.
    PubMed     Abstract available


  14. MAHMUD N, Shah Y, Khan N
    Prevalence of SARS-COV-2 Vaccination and Factors Impacting Likelihood of Vaccination in a Nationwide Veterans Affairs Cohort of IBD Patients.
    Inflamm Bowel Dis. 2022;28:1776-1780.
    PubMed    


  15. CHAPARRO M, Baston-Rey I, Fernandez-Salgado E, Gonzalez Garcia J, et al
    Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study.
    Inflamm Bowel Dis. 2022;28:1725-1736.
    PubMed     Abstract available


  16. ATTAUABI M, Wewer MD, Bendtsen F, Seidelin JB, et al
    Inflammatory Bowel Diseases Affect the Phenotype and Disease Course of Coexisting Immune-Mediated Inflammatory Diseases: A Systematic Review With Meta-Analysis.
    Inflamm Bowel Dis. 2022;28:1756-1765.
    PubMed     Abstract available


  17. PANES J, Bouma G, Ferrante M, Kucharzik T, et al
    INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD Trial.
    Inflamm Bowel Dis. 2022;28:1737-1745.
    PubMed     Abstract available


  18. LIMKETKAI BN, Hamideh M, Shah R, Sauk JS, et al
    Dietary Patterns and Their Association With Symptoms Activity in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2022;28:1627-1636.
    PubMed     Abstract available


  19. INOUE A, Bartlett DJ, Shahraki N, Sheedy SP, et al
    Predicting Risk of Surgery in Patients With Small Bowel Crohn's Disease Strictures Using Computed Tomography and Magnetic Resonance Enterography.
    Inflamm Bowel Dis. 2022;28:1677-1686.
    PubMed     Abstract available


  20. SAVELKOUL EHJ, Thomas PWA, Derikx LAAP, den Broeder N, et al
    Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Nov 1. pii: 6786024. doi: 10.1093.
    PubMed     Abstract available


    October 2022
  21. BOYD T, Friedman S
    Challenges and Opportunities for Advancing Research and Improving Care for Sexual and Gender Minorities With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Oct 29. pii: 6779855. doi: 10.1093.
    PubMed    


  22. GOLD SL, Manning L, Kohler D, Ungaro R, et al
    Micronutrients and Their Role in Inflammatory Bowel Disease: Function, Assessment, Supplementation, and Impact on Clinical Outcomes Including Muscle Health.
    Inflamm Bowel Dis. 2022 Oct 26. pii: 6774890. doi: 10.1093.
    PubMed    


  23. SCOTT FI, Ehrlich O, Wood D, Viator C, et al
    Creation of an Inflammatory Bowel Disease Referral Pathway for Identifying Patients Who Would Benefit From Inflammatory Bowel Disease Specialist Consultation.
    Inflamm Bowel Dis. 2022 Oct 22. pii: 6769932. doi: 10.1093.
    PubMed     Abstract available


  24. AHMED W, Billing W, Stump TE, Strobel T, et al
    Opioid Legislation in Patients With Inflammatory Bowel Disease: A State-wide Retrospective Cohort Study.
    Inflamm Bowel Dis. 2022 Oct 22. pii: 6769933. doi: 10.1093.
    PubMed     Abstract available


  25. BIEDERMANN L, Dubinsky MC, Vermeire S, Fellmann M, et al
    Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open.
    Inflamm Bowel Dis. 2022 Oct 15. pii: 6761656. doi: 10.1093.
    PubMed     Abstract available


  26. BREUGELMANS T, Arras W, Boen LE, Borms E, et al
    Aberrant Mucin Expression Profiles Associate With Pediatric Inflammatory Bowel Disease Presentation and Activity.
    Inflamm Bowel Dis. 2022 Oct 14. pii: 6761121. doi: 10.1093.
    PubMed     Abstract available


  27. LUTZ M, Hayney MS, Farraye FA, Caldera F, et al
    A Note on Monkeypox for Our Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Oct 6. pii: 6749562. doi: 10.1093.
    PubMed    


  28. JORDI SBU, Begre S, Misselwitz B
    Should a Psychologist Be a Mandatory Component of IBD Consults? Yes-Authors' Reply.
    Inflamm Bowel Dis. 2022;28:e138-e139.
    PubMed    


  29. CHEN HM, MacDonald JA
    Molecular Network Analyses Implicate Death-Associated Protein Kinase 3 (DAPK3) as a Key Factor in Colitis-Associated Dysplasia Progression.
    Inflamm Bowel Dis. 2022;28:1485-1496.
    PubMed     Abstract available


  30. ATTAUABI M, Dahlerup JF, Poulsen A, Hansen MR, et al
    Association Between the Clinical, Biochemical, and Endoscopic Activity of Inflammatory Bowel Diseases and Severity and Long-term Outcomes of Coronavirus Disease 2019-A Population-based Study.
    Inflamm Bowel Dis. 2022;28:1618-1622.
    PubMed    


  31. LUPU G, Weaver KN, Herfarth HH, Barnes EL, et al
    Vancomycin Is Effective in the Treatment of Chronic Inflammatory Conditions of the Pouch.
    Inflamm Bowel Dis. 2022;28:1610-1613.
    PubMed    


  32. SANTIAGO M, Dias CC, Alves C, Ministro P, et al
    The Magnitude of Crohn's Disease Direct Costs in Health Care Systems (from Different Perspectives): A Systematic Review.
    Inflamm Bowel Dis. 2022;28:1527-1536.
    PubMed     Abstract available


  33. ADLER J, Eder SJ, Gebremariam A, Moran CJ, et al
    Quantification of Mucosal Activity from Colonoscopy Reports via the Simplified Endoscopic Mucosal Assessment for Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:1537-1542.
    PubMed     Abstract available


  34. TSAI L, McCurdy JD, Ma C, Jairath V, et al
    Epidemiology and Natural History of Perianal Crohn's Disease: A Systematic Review and Meta-Analysis of Population-Based Cohorts.
    Inflamm Bowel Dis. 2022;28:1477-1484.
    PubMed     Abstract available


    September 2022
  35. VUYYURU SK, Brahmania M, Arab JP, Jairath V, et al
    Biologics Are Effective in the Management of Inflammatory Bowel Disease Following Liver Transplantation in Combination With Antirejection Therapy.
    Inflamm Bowel Dis. 2022 Sep 29. pii: 6731264. doi: 10.1093.
    PubMed    


  36. SAFARPOUR AR, Shojaei-Zarghani S, Mehrabi M, Keshtkar AA, et al
    Reply to "Biologics Are Effective in the Management of Inflammatory Bowel Disease Following Liver Transplantation in Combination With Antirejection Therapy".
    Inflamm Bowel Dis. 2022 Sep 29. pii: 6731245. doi: 10.1093.
    PubMed    


  37. TANNER S, Katz J, Cominelli F, Regueiro M, et al
    Inflammatory Bowel Disease and Helicobacter pylori: Protective or Present?
    Inflamm Bowel Dis. 2022 Sep 28. pii: 6726164. doi: 10.1093.
    PubMed    


  38. MULES TC, Swaminathan A, Hirschfeld E, Borichevsky GM, et al
    The Impact of Disease Activity on SD and ED in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Sep 27. pii: 6724308. doi: 10.1093.
    PubMed     Abstract available


  39. TANAKA M, Kawakami A, Sakagami K, Terai T, et al
    Development and Validation of a Japanese Version of the Inflammatory Bowel Disease Self-efficacy Scale and Cross-culture Study in Japan and the United States.
    Inflamm Bowel Dis. 2022 Sep 27. pii: 6723730. doi: 10.1093.
    PubMed     Abstract available


  40. VAN WASSENAER EA, van Rijn RR, Zwetsloot SLM, de Voogd FAE, et al
    Intestinal Ultrasound to Assess Ulcerative Colitis Disease Activity in Children: External Validation and Comparison of 2 Intestinal Ultrasound Activity Indices.
    Inflamm Bowel Dis. 2022 Sep 23. pii: 6712311. doi: 10.1093.
    PubMed     Abstract available


  41. BAKHSHI Z, Yadav S, Harmsen WS, Edakkanambeth Varayil J, et al
    Osteonecrosis in Inflammatory Bowel Disease: Clinical Features, Risk Factor Analysis, and Outcomes.
    Inflamm Bowel Dis. 2022 Sep 23. pii: 6712289. doi: 10.1093.
    PubMed     Abstract available


  42. CHOI B, Sey M, Ponich T, Beaton M, et al
    Decreased Infliximab Concentrations in Patients With Inflammatory Bowel Disease Who Carry a Variable Number Tandem Repeat Polymorphism in the Neonatal Fc Receptor or Variant HLADQA1*05G>A Genotype.
    Inflamm Bowel Dis. 2022 Sep 16. pii: 6702271. doi: 10.1093.
    PubMed     Abstract available


  43. ABDEL-RAHMAN LIH, Morgan XC
    Searching for a Consensus Among Inflammatory Bowel Disease Studies: A Systematic Meta-Analysis.
    Inflamm Bowel Dis. 2022 Sep 16. pii: 6702269. doi: 10.1093.
    PubMed     Abstract available


  44. CALDERA F, Farraye FA, Necela BM, Cogen D, et al
    Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination.
    Inflamm Bowel Dis. 2022 Sep 14. pii: 6697965. doi: 10.1093.
    PubMed     Abstract available


  45. MACEDO SILVA V, Lima Capela T, Freitas M, Curdia Goncalves T, et al
    Humoral Immunogenicity After Vaccination Against SARS-CoV-2 Infection in Inflammatory Bowel Disease Patients Under Immunosuppressive Therapy: Should We Prioritize an Additional Booster Injection?
    Inflamm Bowel Dis. 2022 Sep 13. pii: 6696695. doi: 10.1093.
    PubMed     Abstract available


  46. CROUWEL F, Simsek M, van Doorn AS, Mulder CJJ, et al
    Rectally Administrated Thioguanine for Distal Ulcerative Colitis: A Multicenter Case Series.
    Inflamm Bowel Dis. 2022 Sep 13. pii: 6696694. doi: 10.1093.
    PubMed    


  47. NARKIS B, Hadar E, Barbash-Hazan S, Houri O, et al
    Peripartum Infections Among Women With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Sep 1. pii: 6682832. doi: 10.1093.
    PubMed     Abstract available


  48. MARION L, Amelie B, Zoubir D, Guillaume C, et al
    Histological Indices and Risk of Recurrence in Crohn's Disease: A Retrospective Study of a Cohort of Patients in Endoscopic Remission.
    Inflamm Bowel Dis. 2022;28:1395-1404.
    PubMed     Abstract available


  49. HANZEL J, Sedano R, Jeyarajah J, Zou G, et al
    Similar Clinical Improvement Rates Among Biologic Drug Classes in Crohn's Disease: Systematic Review and Meta-Regression.
    Inflamm Bowel Dis. 2022;28:1462-1464.
    PubMed    


  50. CARTER D, Ben-Horin S, Horesh N, Saukhat O, et al
    Ultrasound-Tomographic Image Fusion: A Novel Imaging Technique for Follow-Up of Penetrating Complications of Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:1451-1453.
    PubMed     Abstract available


  51. PICORARO JA, Shen B
    The Pediatric Pouch Deserves Precision.
    Inflamm Bowel Dis. 2022;28:1469-1471.
    PubMed    


  52. DUBINSKY MC, Mendiolaza ML, Phan BL, Moran HR, et al
    Dashboard-Driven Accelerated Infliximab Induction Dosing Increases Infliximab Durability and Reduces Immunogenicity.
    Inflamm Bowel Dis. 2022;28:1375-1385.
    PubMed     Abstract available


  53. CHIN KOON SIW K, Engel J, Visva S, Mallick R, et al
    Strategies to Distinguish Perianal Fistulas Related to Crohn's Disease From Cryptoglandular Disease: Systematic Review With Meta-Analysis.
    Inflamm Bowel Dis. 2022;28:1363-1374.
    PubMed     Abstract available


  54. HANZEL J, Jairath V, De Cruz P, Guizzetti L, et al
    Recommendations for Standardizing Clinical Trial Design and Endoscopic Assessment in Postoperative Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:1321-1331.
    PubMed     Abstract available


    August 2022
  55. HOYHTYA M, Korpela K, Saqib S, Junkkari S, et al
    Quantitative Fecal Microbiota Profiles Relate to Therapy Response During Induction With Tumor Necrosis Factor alpha Antagonist Infliximab in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Aug 30. pii: 6679143. doi: 10.1093.
    PubMed     Abstract available


  56. VAUGHAN R, Murphy E, Nalder M, Gibson RN, et al
    Infliximab Trough Levels Are Associated With Transmural Sonographic Healing in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Aug 27. pii: 6696163. doi: 10.1093.
    PubMed     Abstract available


  57. WELSH S, Sam Z, Seenan JP, Nicholson GA, et al
    The Role of Appendicectomy in Ulcerative Colitis: Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2022 Aug 26. pii: 6677128. doi: 10.1093.
    PubMed    


  58. ALENEZY N, Nugent Z, Herman S, Zaborniak K, et al
    Aeroallergen-related Diseases Predate the Diagnosis of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Aug 26. pii: 6677127. doi: 10.1093.
    PubMed     Abstract available


  59. DAI C, Huang YH
    The Role of Appendicectomy in Ulcerative Colitis: True or Coincidental Association?
    Inflamm Bowel Dis. 2022 Aug 24. pii: 6674531. doi: 10.1093.
    PubMed    


  60. YU N, Basnayake C
    Vaccinations for Patients With Inflammatory Bowel Disease in Primary Care: An Opportunity for Improvement.
    Inflamm Bowel Dis. 2022 Aug 23. pii: 6674008. doi: 10.1093.
    PubMed    


  61. LI D, Debbas P, Mujukian A, Cheng S, et al
    Postvaccination Symptoms After a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease: Results From CORALE-IBD.
    Inflamm Bowel Dis. 2022 Aug 23. pii: 6673996. doi: 10.1093.
    PubMed     Abstract available


  62. KIM C, Yin Z, Kamdar N, Stidham R, et al
    Vaccination Against Measles, Mumps, Rubella and Incident Inflammatory Bowel Disease in a National Cohort of Privately Insured Children.
    Inflamm Bowel Dis. 2022 Aug 20. pii: 6672842. doi: 10.1093.
    PubMed     Abstract available


  63. ODUFALU FD
    Editorial: Racial Difference in Efficacy of Golimumab in Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Aug 20. pii: 6672843. doi: 10.1093.
    PubMed    


  64. HELLMANN J, Ta A, Ollberding NJ, Bezold R, et al
    Patient-Reported Outcomes Correlate With Microbial Community Composition Independent of Mucosal Inflammation in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Aug 16. pii: 6668484. doi: 10.1093.
    PubMed     Abstract available


  65. KUMAR S, Pollok R, Goldsmith D
    Renal and Urological Disorders Associated With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Aug 9. pii: 6658535. doi: 10.1093.
    PubMed     Abstract available


  66. ALOI M, D'Arcangelo G, Rossetti D, Bucherini S, et al
    Occurrence and Clinical Impact of Eosinophilic Esophagitis in a Large Cohort of Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Aug 9. pii: 6658537. doi: 10.1093.
    PubMed     Abstract available


  67. NAROUS M, Nugent Z, Singh H, Bernstein CN, et al
    Risks of Melanoma and Nonmelanoma Skin Cancers Pre- and Post-Inflammatory Bowel Disease Diagnosis.
    Inflamm Bowel Dis. 2022 Aug 5. pii: 6656176. doi: 10.1093.
    PubMed     Abstract available


  68. YANG JY, Lund JL, Pate V, Kappelman MD, et al
    Utilization of Colonoscopy Following Treatment Initiation in U.S. Commercially Insured Patients With Inflammatory Bowel Disease, 2013-2019.
    Inflamm Bowel Dis. 2022 Aug 5. pii: 6656175. doi: 10.1093.
    PubMed     Abstract available


  69. SOOD A, Singh A, Mahajan R, Midha V, et al
    (Re)Appraising Remission in Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Aug 2. pii: 6653351. doi: 10.1093.
    PubMed     Abstract available


  70. GREYWOODE R, Petralia F, Ullman TA, Frederic Colombel J, et al
    Racial Difference in Efficacy of Golimumab in Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Aug 1. pii: 6652811. doi: 10.1093.
    PubMed     Abstract available


  71. LIBERTUCCI J, Dutta U, Armstrong D
    Letter to the Editor: Too Soon to Dismiss Inflammation-Related Differences in the Mucosa-Associated Microbiota in Crohn's Disease Patients.
    Inflamm Bowel Dis. 2022;28:e120.
    PubMed    


  72. OLAISEN M, Fossmark R
    Reply to "Too Soon to Dismiss Inflammation-Related Differences in the Mucosa-Associated Microbiota in Crohn's Disease Patients".
    Inflamm Bowel Dis. 2022;28:e121.
    PubMed    


  73. BICKSTON SJ, Patrone MV
    Current Venous Thromboembolism Chemoprophylaxis Practices After Surgery for Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2022;28:1296-1297.
    PubMed    


  74. BLAISDELL A, Zhou Y, Kattah MG, Fisher SJ, et al
    Vedolizumab Antagonizes MAdCAM-1-Dependent Human Placental Cytotrophoblast Adhesion and Invasion In Vitro.
    Inflamm Bowel Dis. 2022;28:1219-1228.
    PubMed     Abstract available


  75. HE S, Azar DA, Esfahani FN, Azar GA, et al
    Mechanoscopy: A Novel Device and Procedure for in vivo Detection of Chronic Colitis in Mice.
    Inflamm Bowel Dis. 2022;28:1143-1150.
    PubMed     Abstract available


  76. DAHAR MM, Ramos Rivers C, Ahsan M, Johnston E, et al
    Positive Gluten Sensitivity Serologies and the Impact of Gluten-free Diet in Patients With IBD.
    Inflamm Bowel Dis. 2022;28:e122-e123.
    PubMed    


  77. MOENS A, Verstockt B, Alsoud D, Sabino J, et al
    Translating Results from VARSITY to Real World: Adalimumab vs Vedolizumab as First-line Biological in Moderate to Severe IBD.
    Inflamm Bowel Dis. 2022;28:1135-1142.
    PubMed     Abstract available


  78. ROBLIN X, Serone A, Yoon OK, Zhuo L, et al
    Effects of JAK1-Preferential Inhibitor Filgotinib on Circulating Biomarkers and Whole Blood Genes/Pathways of Patients With Moderately to Severely Active Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:1207-1218.
    PubMed     Abstract available


  79. EVERHOV AH, Kalman TD, Soderling J, Nordenvall C, et al
    Probability of Stoma in Incident Patients With Crohn's Disease in Sweden 2003-2019: A Population-based Study.
    Inflamm Bowel Dis. 2022;28:1160-1168.
    PubMed     Abstract available


  80. NOOR NM, Sousa P, Paul S, Roblin X, et al
    Early Diagnosis, Early Stratification, and Early Intervention to Deliver Precision Medicine in IBD.
    Inflamm Bowel Dis. 2022;28:1254-1264.
    PubMed     Abstract available


    July 2022
  81. TAFT TH, McGarva J, Omprakash TA, Tomasino K, et al
    Hospitalization Experiences and Post-traumatic Stress in Inflammatory Bowel Disease: Opportunities for Change.
    Inflamm Bowel Dis. 2022 Jul 27. pii: 6650637. doi: 10.1093.
    PubMed     Abstract available


  82. GLYNN H, Mikocka-Walus A, Knowles SR
    Editorial: Hospitalization Experiences and Post-traumatic Stress in Inflammatory Bowel Disease: Opportunities for Change.
    Inflamm Bowel Dis. 2022 Jul 27. pii: 6650636. doi: 10.1093.
    PubMed    


  83. GRANT RK, Brindle WM, Arnott IDR
    The Value of a Dedicated IBD Flare Clinic to Effectively Manage Exacerbations of Inflammatory Bowel Disease: The Edinburgh IBD Unit.
    Inflamm Bowel Dis. 2022 Jul 22. pii: 6648508. doi: 10.1093.
    PubMed    


  84. HSU C, Ghannoum M, Cominelli F, Martino LD, et al
    Mycobiome and Inflammatory Bowel Disease: Role in Disease Pathogenesis, Current Approaches and Novel Nutritional-based Therapies.
    Inflamm Bowel Dis. 2022 Jul 19. pii: 6646155. doi: 10.1093.
    PubMed     Abstract available



  85. Correction to: Association Between Inflammatory Bowel Disease and Dementia: A Longitudinal Cohort Study.
    Inflamm Bowel Dis. 2022 Jul 18. pii: 6645873. doi: 10.1093.
    PubMed    


  86. CROSBY S, Schuh MJ, Becker M, Ivanov M, et al
    New Pneumococcal Vaccines for Prevention of Invasive Pneumococcal Disease in Adult Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Jul 13. pii: 6643251. doi: 10.1093.
    PubMed     Abstract available


  87. WEAVER KN, Zhang X, Dai X, Chen W, et al
    Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Jul 13. pii: 6643250. doi: 10.1093.
    PubMed    


  88. LIU JJ, Abraham BP, Adamson P, Barnes EL, et al
    The Current State of Care for Black and Hispanic Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2022 Jul 11. pii: 6639794. doi: 10.1093.
    PubMed     Abstract available


  89. BUISSON A, Serrero M, Orsat L, Nancey S, et al
    Comparative Acceptability of Therapeutic Maintenance Regimens in Patients With Inflammatory Bowel Disease: Results From the Nationwide ACCEPT2 Study.
    Inflamm Bowel Dis. 2022 Jul 11. pii: 6639655. doi: 10.1093.
    PubMed     Abstract available


  90. SHARMA N
    Should a Psychologist Be a Mandatory Component of Inflammatory Bowel Disease Consults? Yes.
    Inflamm Bowel Dis. 2022 Jul 6. pii: 6632462. doi: 10.1093.
    PubMed    


  91. LOFTUS EV, Baumgart DC, Gecse K, Kinnucan JA, et al
    Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program.
    Inflamm Bowel Dis. 2022 Jul 6. pii: 6632473. doi: 10.1093.
    PubMed     Abstract available


  92. YUAN W, Marwaha JS, Rakowsky ST, Palmer NP, et al
    Trends in Medical Management of Moderately to Severely Active Ulcerative Colitis: A Nationwide Retrospective Analysis.
    Inflamm Bowel Dis. 2022 Jul 4. pii: 6628670. doi: 10.1093.
    PubMed     Abstract available


  93. XU F, deJong N, Kappelman MD, Greenlund KJ, et al
    Primary Care Professionals' Attitudes Towards Vaccination Recommendation for Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Jul 2. pii: 6627525. doi: 10.1093.
    PubMed     Abstract available


  94. SAFARPOUR AR, Shojaei-Zarghani S, Mehrabi M, Keshtkar AA, et al
    Alterations in the Course of Inflammatory Bowel Disease Following Liver Transplantation: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2022 Jul 2. pii: 6627524. doi: 10.1093.
    PubMed     Abstract available


  95. HOLMGREN J, Froborg A, Visuri I, Halfvarson J, et al
    The Risk of Serious Infections Before and After Anti-TNF Therapy in Inflammatory Bowel Disease: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2022 Jul 1. pii: 6625867. doi: 10.1093.
    PubMed     Abstract available


  96. GONZALEZ-BERNARDO O, Riestra S
    Reply to "Virtual Chromoendoscopy vs High-definition White Light Endoscopy Using iSCAN".
    Inflamm Bowel Dis. 2022;28:e107.
    PubMed    


  97. JURICKOVA I, Bonkowski E, Angerman E, Novak E, et al
    Eicosatetraynoic Acid and Butyrate Regulate Human Intestinal Organoid Mitochondrial and Extracellular Matrix Pathways Implicated in Crohn's Disease Strictures.
    Inflamm Bowel Dis. 2022;28:988-1003.
    PubMed     Abstract available


  98. WEAVER KN, Herfarth HH, Barnes EL
    Antibiotic Use Patterns in the Management of Chronic Pouchitis.
    Inflamm Bowel Dis. 2022;28:e92-e93.
    PubMed    


  99. CAO X, Yuan H, Liang J, Huang H, et al
    Elective Switching on Biosimilars: Far More Than Nonmedical Switching.
    Inflamm Bowel Dis. 2022;28:e101-e102.
    PubMed    


  100. KAYAL M, Plietz M, Wang YHW, Khaitov S, et al
    Crohn's Disease Like Pouch Inflammation Is Associated With Decreased Odds of Secondary Ileostomy Closure After Ileal Pouch Anal Anastomosis.
    Inflamm Bowel Dis. 2022;28:1123-1125.
    PubMed    


  101. BAR N, Avraham Y, Dubinsky V, Cohen NA, et al
    Long-term Antibiotic Treatment in Pouchitis-Patterns of Use and Safety.
    Inflamm Bowel Dis. 2022;28:1027-1033.
    PubMed     Abstract available


  102. WIJNANDS AM, Te Groen M, Peters Y, Kaptein AA, et al
    Patients Prioritize a Low-volume Bowel Preparation in Colitis-associated Colorectal Cancer Surveillance: A Discrete Choice Experiment.
    Inflamm Bowel Dis. 2022;28:1053-1060.
    PubMed     Abstract available


  103. D'HAENS GR, Reinisch W, Lee SD, Tarabar D, et al
    Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn's Disease: The OPERA II Study.
    Inflamm Bowel Dis. 2022;28:1034-1044.
    PubMed     Abstract available


    June 2022
  104. CLAXTON BB, Sun G, Nahar R, Henry C, et al
    Myocardial Infarction With Nonobstructive Coronary Arteries in New-onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Jun 30. pii: 6623438. doi: 10.1093.
    PubMed    


  105. HARLAN NP, Roberts J, Siegel C, Buckey JC, et al
    Hyperbaric Oxygen as Successful Monotherapy for a Severe Ulcerative Colitis Flare.
    Inflamm Bowel Dis. 2022 Jun 30. pii: 6623436. doi: 10.1093.
    PubMed    


  106. EL HAGE CHEHADE N, Ghoneim S, Shah S, Chahine A, et al
    Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials.
    Inflamm Bowel Dis. 2022 Jun 29. pii: 6619552. doi: 10.1093.
    PubMed     Abstract available


  107. WELSH S, Sam Z, Seenan JP, Nicholson GA, et al
    The Role of Appendicectomy in Ulcerative Colitis: Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2022 Jun 29. pii: 6619547. doi: 10.1093.
    PubMed     Abstract available


  108. PREZIOSI NA, Rizvi AH, Feerick JD, Mandelia C, et al
    De Novo Pediatric Ulcerative Colitis Triggered by SARS-CoV-2 Infection: a Tale of 2 Sisters.
    Inflamm Bowel Dis. 2022 Jun 28. pii: 6619087. doi: 10.1093.
    PubMed    


  109. SEDANO R, Hogan M, Zou G, Narula N, et al
    Comparison of the Relative Sensitivity of Clinical, Endoscopic, and Histologic Remission for Detection of Treatment Efficacy in Ulcerative Colitis Trials.
    Inflamm Bowel Dis. 2022 Jun 24. pii: 6617565. doi: 10.1093.
    PubMed    


  110. INNOCENTI T, Bigagli E, Lynch EN, Galli A, et al
    MiRNA-Based Therapies for the Treatment of Inflammatory Bowel Disease: What Are We Still Missing?
    Inflamm Bowel Dis. 2022 Jun 24. pii: 6617564. doi: 10.1093.
    PubMed     Abstract available


  111. ARJOMAND FARD N, Armstrong H, Perry T, Wine E, et al
    Appendix and Ulcerative Colitis: a Key to Explaining the Pathogenesis and Directing Novel Therapies?
    Inflamm Bowel Dis. 2022 Jun 24. pii: 6617562. doi: 10.1093.
    PubMed     Abstract available


  112. LIU E, Laube R, Leong RW, Fraser A, et al
    Managing Inflammatory Bowel Disease in Pregnancy: Health Care Professionals' Involvement, Knowledge, and Decision Making.
    Inflamm Bowel Dis. 2022 Jun 17. pii: 6609865. doi: 10.1093.
    PubMed     Abstract available


  113. JORDAN A, Maraj B, Kinnucan J
    Is it a Flare? Acute Appendicitis in Ulcerative Colitis Patient Found on Routine Screening Colonoscopy.
    Inflamm Bowel Dis. 2022 Jun 14. pii: 6608386. doi: 10.1093.
    PubMed    


  114. LONG MD, Afzali A, Fischer M, Hudesman D, et al
    Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting.
    Inflamm Bowel Dis. 2022 Jun 14. pii: 6608417. doi: 10.1093.
    PubMed     Abstract available


  115. KAWAMOTO A, Fujii T, Mitani R, Suzuki Y, et al
    Serum Levels of Infliximab Biosimilar in a Child Delivered From a Mother Treated for Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Jun 14. pii: 6608379. doi: 10.1093.
    PubMed    


  116. STAFFORD IS, Gosink MM, Mossotto E, Ennis S, et al
    A Systematic Review of Artificial Intelligence and Machine Learning Applications to Inflammatory Bowel Disease, with Practical Guidelines for Interpretation.
    Inflamm Bowel Dis. 2022 Jun 14. pii: 6608231. doi: 10.1093.
    PubMed     Abstract available


  117. TIAN WN, Huang YH, Dai C
    Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: A Survey From China.
    Inflamm Bowel Dis. 2022 Jun 6. pii: 6603234. doi: 10.1093.
    PubMed    


  118. JEDEL S, Beck T, Swanson G, Hood MM, et al
    Mindfulness Intervention Decreases Frequency and Severity of Flares in Inactive Ulcerative Colitis Patients: Results of a Phase II, Randomized, Placebo-Controlled Trial.
    Inflamm Bowel Dis. 2022 Jun 4. pii: 6602039. doi: 10.1093.
    PubMed     Abstract available


  119. TURSI A, Nenna R
    COVID-19 as a Trigger for De Novo Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:e76-e77.
    PubMed    


  120. ZHANG Y, Tian F, Li H
    Pulmonary Infection Due to Reactivation of Latent Epstein-Barr Virus in a Patient With Crohn's Disease Treated With Infliximab.
    Inflamm Bowel Dis. 2022;28:e80-e81.
    PubMed    


  121. STIDHAM RW, Yu D, Zhao X, Bishu S, et al
    Identifying the Presence, Activity, and Status of Extraintestinal Manifestations of Inflammatory Bowel Disease Using Natural Language Processing of Clinical Notes.
    Inflamm Bowel Dis. 2022 Jun 3. pii: 6601382. doi: 10.1093.
    PubMed     Abstract available


  122. YU M, Zhu W, Wang J, Chen X, et al
    Caveolin-1 Alleviates Crohn's Disease-induced Intestinal Fibrosis by Inhibiting Fibroblasts Autophagy Through Modulating Sequestosome 1.
    Inflamm Bowel Dis. 2022;28:923-935.
    PubMed     Abstract available


  123. WANG B, Li R, Zhang S, Zhao Q, et al
    A Case of Behcet's Disease With Hepatic Lesions Misdiagnosed as Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:e86-e87.
    PubMed    


  124. DONG G, Yang Y, Zhang H, Yu W, et al
    Protein Kinase CK2 Maintains Reciprocal Balance Between Th17 and Treg Cells in the Pathogenesis of UC.
    Inflamm Bowel Dis. 2022;28:830-842.
    PubMed     Abstract available


  125. WANG X, Tang J, Zheng JW, Huang WF, et al
    Granulomatous Pneumonia and Liver Lesions Associated With Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:e78-e79.
    PubMed    


  126. SORENSEN KM, Jensen CH, Sheikh SP, Qvist N, et al
    Treatment of Fistulizing Perianal Crohn's Disease by Autologous Microfat Enriched With Adipose-Derived Regenerative Cells.
    Inflamm Bowel Dis. 2022;28:967-970.
    PubMed    


  127. FRADKOV E, Sheehan J, Cushing K, Higgins PDR, et al
    Efficacy of Ustekinumab in Crohn's Disease With and Without Concurrent Autoimmune Skin Disease.
    Inflamm Bowel Dis. 2022;28:895-904.
    PubMed     Abstract available


  128. CHEN G, Pedarla V, Null KD, Cazzetta SE, et al
    Health Care Costs and Resource Utilization Among Patients With Crohn's Disease With and Without Perianal Fistula.
    Inflamm Bowel Dis. 2022;28:870-877.
    PubMed     Abstract available


  129. JAVAID A, Shahab O, Adorno W, Fernandes P, et al
    Machine Learning Predictive Outcomes Modeling in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2022;28:819-829.
    PubMed     Abstract available


  130. NOORIAN S, Jeon Y, Nguyen MT, Sauk J, et al
    The Impact of NAFLD on Hospitalization Outcomes in Patients With Inflammatory Bowel Diseases: Nationwide Analysis.
    Inflamm Bowel Dis. 2022;28:878-887.
    PubMed     Abstract available


  131. WITGES K, Sexton K, Graff LA, Targownik LE, et al
    What Is a Flare? The Manitoba Living With IBD Study.
    Inflamm Bowel Dis. 2022;28:862-869.
    PubMed     Abstract available


  132. BROMS G
    IBD in the Postpartum Period: Spotlight on Maternal Outcomes.
    Inflamm Bowel Dis. 2022;28:980-981.
    PubMed    


  133. ABOUBAKR A, Gottlieb ZS, Riggs AR, Johnson SO, et al
    Peripartum Exposure to Biologic Therapy Does Not Impact Postpartum Wound Healing in Women With IBD.
    Inflamm Bowel Dis. 2022;28:843-849.
    PubMed     Abstract available


  134. RANGEL PANIZ G, Lebow J, Sim L, Lacy BE, et al
    Eating Disorders: Diagnosis and Management Considerations for the IBD Practice.
    Inflamm Bowel Dis. 2022;28:936-946.
    PubMed    


  135. CAO Q, Chen C, Gao X, Chen Y, et al
    Real-world Short-term Effectiveness of Ustekinumab in Crohn's Disease: Results from a Multicenter, Prospective Study in China.
    Inflamm Bowel Dis. 2022;28.
    PubMed    


  136. PENG L, Hu S, Yu Q, Chen Y, et al
    Challenging the Surge of Inflammatory Bowel Disease: The Role of the China Crohn's and Colitis Foundation in the Healthcare Landscape of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022;28.
    PubMed     Abstract available


  137. CHEN YJ, Chen BL, Liang MJ, Chen SL, et al
    Longitudinal Bowel Behavior Assessed by Bowel Ultrasound to Predict Early Response to Anti-TNF Therapy in Patients With Crohn's Disease: A Pilot Study.
    Inflamm Bowel Dis. 2022;28.
    PubMed     Abstract available


  138. ARKENBOSCH JHC, Mak JWY, Ho JCL, Beelen EMJ, et al
    Indications, Postoperative Management, and Long-term Prognosis of Crohn's Disease After Ileocecal Resection: A Multicenter Study Comparing the East and West.
    Inflamm Bowel Dis. 2022;28.
    PubMed     Abstract available


  139. YAO L, Chen H, Shao B, Liu J, et al
    Temporal Changes in the Treatment Paradigm and Long-term Prognosis of Patients With Crohn's Disease: A Hospital-Based Cohort Study in China.
    Inflamm Bowel Dis. 2022;28.
    PubMed     Abstract available


  140. BAI X, Zhang H, Ruan G, Lv H, et al
    Long-term Disease Behavior and Surgical Intervention Analysis in Hospitalized Patients With Crohn's Disease in China: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2022;28.
    PubMed     Abstract available


  141. WINTHROP KL, Vermeire S, Long MD, Panes J, et al
    Long-term Risk of Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib.
    Inflamm Bowel Dis. 2022 Jun 1. pii: 6596831. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  142. TSE CS, Melmed GY, Siegel CA, Weng CH, et al
    Bidirectional Correlations Between Health Confidence and Inflammatory Bowel Disease Activity: A Nationwide Longitudinal Cohort Study.
    Inflamm Bowel Dis. 2022 May 28. pii: 6594471. doi: 10.1093.
    PubMed    


  143. WINTER RW, Boyd T, Chan WW, Levy AN, et al
    Risk Factors for Voluntary Childlessness in Men and Women With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 May 28. pii: 6594473. doi: 10.1093.
    PubMed    


  144. WU S, Xie S, Yuan C, Yang Z, et al
    Inflammatory Bowel Disease and Long-term Risk of Cancer: A Prospective Cohort Study Among Half a Million Adults in UK Biobank.
    Inflamm Bowel Dis. 2022 May 27. pii: 6594105. doi: 10.1093.
    PubMed     Abstract available


  145. SOOKAROMDEE P, Wiwanitkit V
    Correspondence on "Immunogenicity of COVID-19 Vaccine Doses in Patients With Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2022 May 27. pii: 6594100. doi: 10.1093.
    PubMed    


  146. GOLD SL, Rabinowitz LG, Manning L, Keefer L, et al
    High Prevalence of Malnutrition and Micronutrient Deficiencies in Patients With Inflammatory Bowel Disease Early in Disease Course.
    Inflamm Bowel Dis. 2022 May 19. pii: 6589577. doi: 10.1093.
    PubMed     Abstract available


  147. GOODYEAR BG, Heidari F, Ingram RJM, Cortese F, et al
    Multimodal Brain MRI of Deep Gray Matter Changes Associated With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 May 19. pii: 6589553. doi: 10.1093.
    PubMed     Abstract available


  148. SLEUTJES JAM, Roeters van Lennep JE, van der Woude CJ, de Vries AC, et al
    Lipid Changes After Induction Therapy in Patients with Inflammatory Bowel Disease: Effect of Different Drug Classes and Inflammation.
    Inflamm Bowel Dis. 2022 May 19. pii: 6589576. doi: 10.1093.
    PubMed     Abstract available


  149. KAWASHIMA K, Oshima N, Kishimoto K, Kataoka M, et al
    Low Fecal Calprotectin Predicts Histological Healing in Patients with Ulcerative Colitis with Endoscopic Remission and Leads to Prolonged Clinical Remission.
    Inflamm Bowel Dis. 2022 May 18. pii: 6588003. doi: 10.1093.
    PubMed     Abstract available


  150. MADSEN GR, Bertl K, Pandis N, Stavropoulos A, et al
    The Impact of Periodontitis on Inflammatory Bowel Disease Activity.
    Inflamm Bowel Dis. 2022 May 12. pii: 6584926. doi: 10.1093.
    PubMed     Abstract available


  151. DE KRIJGER M, Carvalho B, Rausch C, Bolijn AS, et al
    Genetic Profiling of Colorectal Carcinomas of Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 May 11. pii: 6584483. doi: 10.1093.
    PubMed     Abstract available


  152. RIZVI A, Trivedi P, Bar-Mashiah A, Plietz M, et al
    Vitamin D Deficiency is Common in Patients with Ulcerative Colitis After Total Proctocolectomy with Ileal Pouch Anal Anastomosis.
    Inflamm Bowel Dis. 2022 May 11. pii: 6584485. doi: 10.1093.
    PubMed    


  153. DE SIRE R, Rispo A, Compare D, Tortora F, et al
    Wernicke Encephalopathy in Ulcerative Colitis.
    Inflamm Bowel Dis. 2022;28:e70-e71.
    PubMed    


  154. BATTAT R
    Authors' Reply to "Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2022;28:e61.
    PubMed    


  155. MC GETTIGAN N, Boland K, O'Toole A
    Letter to the Editor in Response to "Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2022;28:e59-e60.
    PubMed    


  156. PEREZ K, Ngollo M, Rabinowitz K, Hammoudi N, et al
    Meta-Analysis of IBD Gut Samples Gene Expression Identifies Specific Markers of Ileal and Colonic Diseases.
    Inflamm Bowel Dis. 2022;28:775-782.
    PubMed     Abstract available


  157. ETWEBI Z, Goldsmith JR, Bou-Dargham M, Tian Y, et al
    TIPE2 Promotes Tumor Initiation But Inhibits Tumor Progression in Murine Colitis-Associated Colon Cancer.
    Inflamm Bowel Dis. 2022;28:764-774.
    PubMed     Abstract available


  158. NIGAM GB, Patel RN, Lakhtakia S, Desai D, et al
    A Survey of Endoscopists' Views on Dysplasia Surveillance and Chromoendoscopy in IBD from India.
    Inflamm Bowel Dis. 2022;28:e64-e65.
    PubMed    


  159. GOLUSDA L, Kuhl AA, Siegmund B, Paclik D, et al
    Reducing Pain in Experimental Models of Intestinal Inflammation Affects the Immune Response.
    Inflamm Bowel Dis. 2022;28:801-807.
    PubMed     Abstract available


  160. ZHAO QF, Wang S
    Crohn's Disease Complicated by an Ileo-urachal Fistula.
    Inflamm Bowel Dis. 2022;28:e62-e63.
    PubMed    


  161. HUANG JS, Definis M, Cruz R, Parker J, et al
    Patient Portal Usage: An Objective Target for Transition Interventions Among Youth with IBD?
    Inflamm Bowel Dis. 2022;28:808-810.
    PubMed    


  162. ROBLIN X, Genin C, Nancey S, Williet N, et al
    Swapping Versus Dose Optimization in Patients Losing Response to Adalimumab With Adequate Drug Levels.
    Inflamm Bowel Dis. 2022;28:720-727.
    PubMed     Abstract available


  163. GU P, Chhabra A, Chittajallu P, Chang C, et al
    Visceral Adipose Tissue Volumetrics Inform Odds of Treatment Response and Risk of Subsequent Surgery in IBD Patients Starting Antitumor Necrosis Factor Therapy.
    Inflamm Bowel Dis. 2022;28:657-666.
    PubMed     Abstract available


  164. BRENNER EJ, Long MD, Mann CM, Lin L, et al
    Anxiety and Depressive Symptoms Are Not Associated With Future Pediatric Crohn's Disease Activity.
    Inflamm Bowel Dis. 2022;28:728-733.
    PubMed     Abstract available


  165. DE CRUZ P, Hamilton AL, Burrell KJ, Gorelik A, et al
    Endoscopic Prediction of Crohn's Disease Postoperative Recurrence.
    Inflamm Bowel Dis. 2022;28:680-688.
    PubMed     Abstract available


    April 2022
  166. LEBER A, Hontecillas R, Tubau-Juni N, Lichtiger S, et al
    Correction to: Efficacy, Safety, and Tolerability of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Apr 30. pii: 6576383. doi: 10.1093.
    PubMed    


  167. NELSON AD, Elkins JR, Stocchi L, Farraye FA, et al
    Use and Misuse of Parenteral Nutrition in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Apr 26. pii: 6574514. doi: 10.1093.
    PubMed     Abstract available


  168. TORTORA C, Di Paola A, Creoli M, Argenziano M, et al
    Effects of CB2 and TRPV1 Stimulation on Osteoclast Overactivity Induced by Iron in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Apr 26. pii: 6574513. doi: 10.1093.
    PubMed     Abstract available


  169. FRIEDMAN S, Zegers FD, Jolving LR, Nielsen J, et al
    Increased Risk of Postpartum Infections After Caesarian and Vaginal Delivery in Women With Inflammatory Bowel Disease: A Danish Nationwide Cohort Study.
    Inflamm Bowel Dis. 2022 Apr 26. pii: 6574515. doi: 10.1093.
    PubMed     Abstract available


  170. KWON JY, Daoud ND, Hashash JG, Picco MF, et al
    Efficacy of Hepatitis B Vaccination with a Novel Immunostimulatory Sequence Adjuvant (Heplisav-B) in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Apr 25. pii: 6573907. doi: 10.1093.
    PubMed     Abstract available


  171. VELOSO FT
    Are Ulcerative Colitis and Diverticulitis Connected by the Same Hub?
    Inflamm Bowel Dis. 2022 Apr 23. pii: 6573214. doi: 10.1093.
    PubMed    


  172. HASAN B, Ur Rahman A
    Ulcerative Colitis and Diverticulitis Are Possibly Connected to the Same Hub.
    Inflamm Bowel Dis. 2022 Apr 23. pii: 6573283. doi: 10.1093.
    PubMed    


  173. MAO R, Ng SC, Chen M
    Network Clinical Collaboration to Improve Quality of Care of Patients with Inflammatory Bowel Disease in China.
    Inflamm Bowel Dis. 2022 Apr 20. pii: 6571486. doi: 10.1093.
    PubMed    


  174. MIKOLAJCZYK AE, Cohen NA, Watson S, Ackerman M, et al
    Assessment of the Degree of Variation of Histologic Inflammation in Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Apr 18. pii: 6569959. doi: 10.1093.
    PubMed     Abstract available


  175. ZIV Y, Swaminath A, Sultan K
    Patient With Ulcerative Colitis and Failure of Ustekinumab Responds to Risankizumab: Similar Is Not Identical.
    Inflamm Bowel Dis. 2022 Apr 13. pii: 6568039. doi: 10.1093.
    PubMed    


  176. LI D, Xu A, Mengesha E, Elyanow R, et al
    The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy.
    Inflamm Bowel Dis. 2022 Apr 9. pii: 6565880. doi: 10.1093.
    PubMed    


  177. SEONG G, Song JH, Kim JE, Kim TJ, et al
    Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1.
    Inflamm Bowel Dis. 2022 Apr 9. pii: 6565877. doi: 10.1093.
    PubMed     Abstract available


  178. SCHELL TL, Knutson KL, Saha S, Wald A, et al
    Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Apr 9. pii: 6565876. doi: 10.1093.
    PubMed    


  179. MASUTA Y, Watanabe T, Minaga K, Kudo M, et al
    Reply to Response to "'A Case of Ulcerative Colitis Relapse Characterized by Systemic Type I Interferon Responses After COVID-19 Vaccination'" by Mungmunpuntipantip and Wiwanitkiton.
    Inflamm Bowel Dis. 2022 Apr 8. pii: 6565439. doi: 10.1093.
    PubMed    


  180. MUNGMUNPUNTIPANTIP R, Wiwanitkit V
    Ulcerative Colitis Relapse After COVID-19 Vaccination: Correspondence.
    Inflamm Bowel Dis. 2022 Apr 8. pii: 6565438. doi: 10.1093.
    PubMed    


  181. VALENTIN S, Renel B, Manneville F, Caron B, et al
    Prevalence of and Factors Associated with Respiratory Symptoms Among Patients with Inflammatory Bowel Disease: A Prospective Study.
    Inflamm Bowel Dis. 2022 Apr 8. pii: 6565436. doi: 10.1093.
    PubMed     Abstract available


  182. MACALUSO FS, Giuliano A, Fries W, Viola A, et al
    Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.
    Inflamm Bowel Dis. 2022 Apr 6. pii: 6564282. doi: 10.1093.
    PubMed     Abstract available


  183. KUANG R, O'Keefe SJD, Ramos Del Aguila de Rivers C, Koutroumpakis F, et al
    Is Salt at Fault? Dietary Salt Consumption and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Apr 5. pii: 6563753. doi: 10.1093.
    PubMed     Abstract available


  184. DUBINSKY MC, Magro F, Steinwurz F, Hudesman DP, et al
    Association of C-reactive Protein and Partial Mayo Score With Response to Tofacitinib Induction Therapy: Results From the Ulcerative Colitis Clinical Program.
    Inflamm Bowel Dis. 2022 Apr 5. pii: 6563756. doi: 10.1093.
    PubMed     Abstract available


  185. AGRAWAL M, Petralia F, Tepler A, Durbin L, et al
    Gender-Based Differences in Response to Tumor Necrosis Factor Inhibitor Therapies for Ulcerative Colitis: Individual Participant Data Meta-Analyses of Clinical Trials.
    Inflamm Bowel Dis. 2022 Apr 2. pii: 6562696. doi: 10.1093.
    PubMed     Abstract available


  186. BERGAMASCHI G, Castiglione F, D'Inca R, Astegiano M, et al
    Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study.
    Inflamm Bowel Dis. 2022 Apr 2. pii: 6562695. doi: 10.1093.
    PubMed     Abstract available


  187. ZHANG W, Scalori A, Fuh F, McBride J, et al
    Correction to: Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease: Results from a Phase 1 Randomized Trial.
    Inflamm Bowel Dis. 2022 Apr 2. pii: 6562694. doi: 10.1093.
    PubMed    


  188. FAYE AS, Dodson JA, Shaukat A
    Sarcopenia as a Risk Prediction Tool in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Apr 2. pii: 6562699. doi: 10.1093.
    PubMed    


    March 2022
  189. COATES MD, Ba DM, Liu G, Dalessio S, et al
    Response to the Letter to the Editor: "Re-Revisiting the Association Between Inflammatory Bowel Disease and Parkinson's Disease".
    Inflamm Bowel Dis. 2022 Mar 31. pii: 6561784. doi: 10.1093.
    PubMed    


  190. PATIL SA, Bhat S, Limdi JK, Farraye FA, et al
    The Sincerest Form of Flattery? Biosimilars in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Mar 30. pii: 6556005. doi: 10.1093.
    PubMed    


  191. MUNGMUNPUNTIPANTIP R, Wiwanitkit V
    Response to: COVID-19 Vaccination, Willingness, Hesitancy, and Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2022;28:e45.
    PubMed    


  192. COSTANTINO A, Noviello D, Costantino C, Vecchi M, et al
    Letter of Reply to "Response to: COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association".
    Inflamm Bowel Dis. 2022;28:e57-e58.
    PubMed    


  193. SCHRODER AL, Chami B, Liu Y, Doyle CM, et al
    Neutrophil Extracellular Trap Density Increases With Increasing Histopathological Severity of Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:586-598.
    PubMed     Abstract available


  194. CHANDRASEKHARAN B, Boyer D, Owens JA, Wolfarth AA, et al
    Intracolonic Neuropeptide Y Y1 Receptor Inhibition Attenuates Intestinal Inflammation in Murine Colitis and Cytokine Release in IBD Biopsies.
    Inflamm Bowel Dis. 2022;28:502-513.
    PubMed     Abstract available


  195. LIGHTNER AL, Buhulaigah H, Zaghiyan K, Holubar SD, et al
    Is Intestinal Diversion an Effective Treatment for Distal Crohn's Disease?
    Inflamm Bowel Dis. 2022;28:547-552.
    PubMed     Abstract available


  196. LAWRENCE LS, Heider A, Singer AAM, Neef HC, et al
    Granulomas in Diagnostic Biopsies Associated With High Risk of Crohn's Complications-But May Be Preventable.
    Inflamm Bowel Dis. 2022;28:523-530.
    PubMed     Abstract available


  197. GANDHI S, Zelman S, De Armas RE, Hemond C, et al
    Natural History of New-onset Inflammatory Bowel Disease Among Patients With Multiple Sclerosis.
    Inflamm Bowel Dis. 2022 Mar 26. pii: 6554576. doi: 10.1093.
    PubMed    


  198. DASHARATHY SS, Long MD, Lackner JM, Ben-Ami Shor D, et al
    Psychological Factors Associated With Adherence to Oral Treatment in Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Mar 24. pii: 6553867. doi: 10.1093.
    PubMed     Abstract available


  199. GREYWOODE R, Ullman T, Keefer L
    National Prevalence of Psychological Distress and Use of Mental Health Care in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Mar 24. pii: 6553591. doi: 10.1093.
    PubMed     Abstract available


  200. RANA T
    Influence and Implications of the Molecular Paradigm of Nitric Oxide Underlying Inflammatory Reactions of the Gastrointestinal Tract of Dog: A Major Hallmark of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Mar 21. pii: 6551624. doi: 10.1093.
    PubMed     Abstract available


  201. PETERSON AR, Srinivasan A, Proud D, Jackett L, et al
    Synchronous Multifocal Adenomatous Dysplasia and Post-transplant Lymphoproliferative Disorder Confined to the Colon in a Patient with Ulcerative Colitis After Liver Transplant.
    Inflamm Bowel Dis. 2022 Mar 15. pii: 6548883. doi: 10.1093.
    PubMed    


  202. CHRISTENSEN B, Prentice RE, Al-Ani AH, Zhang E, et al
    Self-Reported Failure to Address Sexual Function in Patients With Inflammatory Bowel Disease by Gastroenterologists: Barriers and Areas for Improvement.
    Inflamm Bowel Dis. 2022 Mar 14. pii: 6548311. doi: 10.1093.
    PubMed    


  203. NOGUCHI T, Ando T, Emoto S, Nozawa H, et al
    Artificial Intelligence Program to Predict p53 Mutations in Ulcerative Colitis-Associated Cancer or Dysplasia.
    Inflamm Bowel Dis. 2022 Mar 12. pii: 6547691. doi: 10.1093.
    PubMed     Abstract available


  204. HAASNOOT ML, Mookhoek A, Duijvestein M, D'Haens GRAM, et al
    Prognostic Value of Colonic Tissue and Blood Eosinophils in Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Mar 11. pii: 6547139. doi: 10.1093.
    PubMed     Abstract available


  205. PETER I, Dubinsky M, Xuan S, Chen N, et al
    Letter to the Editor: Re-Revisiting the Association Between Inflammatory Bowel Disease and Parkinson's Disease.
    Inflamm Bowel Dis. 2022 Mar 10. pii: 6546455. doi: 10.1093.
    PubMed    


  206. SHEN J, Liang J, Mao R, Ran Z, et al
    Secondary Indicators for an Evaluation and Guidance System for Quality of Care in Inflammatory Bowel Disease Centers: A Critical Review of the Inflammatory Bowel Disease Quality of Care Center.
    Inflamm Bowel Dis. 2022 Mar 5. pii: 6542945. doi: 10.1093.
    PubMed     Abstract available


  207. OZSOY M, Stummer N, Zimmermann FA, Feichtinger RG, et al
    Role of Energy Metabolism and Mitochondrial Function in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Mar 5. pii: 6542923. doi: 10.1093.
    PubMed     Abstract available


  208. SPIERA E, Ganjian DY, Zhang X, Brenner EJ, et al
    Outcomes of COVID-19 Infections in Vaccinated Patients with Inflammatory Bowel Disease: Data From an International Registry.
    Inflamm Bowel Dis. 2022 Mar 3. pii: 6541762. doi: 10.1093.
    PubMed    


  209. HUDHUD D, Caldera F, Cross RK
    Addressing COVID-19 Vaccine Hesitancy in Patients with IBD.
    Inflamm Bowel Dis. 2022;28:492-493.
    PubMed    


  210. COSTANTINO A, Noviello D, Conforti FS, Aloi M, et al
    COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.
    Inflamm Bowel Dis. 2022;28:474-478.
    PubMed    


  211. YU B, Lin C, Yang Y, Yang YF, et al
    Spontaneous Perforation in Crohn's Disease: A Report of Two Cases.
    Inflamm Bowel Dis. 2022;28:e40-e42.
    PubMed    


  212. RAGHAVA RG, Sharma V, Malegaonkar SK, Dhooria S, et al
    Tracheobronchial Crohn's Disease: Case Report and Systematic Review of the Literature.
    Inflamm Bowel Dis. 2022;28:e33-e35.
    PubMed    


  213. SOFIA C, Adiletta V, Iovene B, Sgalla G, et al
    Acute Respiratory Distress Syndrome and Lung Fibrosis Complicating Surgery in a Patient With Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:e31-e32.
    PubMed    


  214. DULANEY D, Dave P, Walsh S, Mehandru S, et al
    Noninfectious Pulmonary Complications Associated With Anti-Integrin Therapy: A Case Report and Systematic Review of the Literature.
    Inflamm Bowel Dis. 2022;28:479-483.
    PubMed    


  215. NICOLETTI F, Hammer L, Furtado S, Mangano K, et al
    Oral Delivery of Encapsulated All-Trans Retinoic Acid Ameliorates Disease in Rodent Models of Colitis.
    Inflamm Bowel Dis. 2022;28:455-465.
    PubMed     Abstract available


  216. BISCAGLIA G, Latiano A, Castellana S, Fontana R, et al
    Germline Alterations in Patients With IBD-associated Colorectal Cancer.
    Inflamm Bowel Dis. 2022;28:447-454.
    PubMed     Abstract available


  217. MARK-CHRISTENSEN A, Lange A, Erichsen R, Froslev T, et al
    Early-Life Exposure to Antibiotics and Risk for Crohn's Disease: A Nationwide Danish Birth Cohort Study.
    Inflamm Bowel Dis. 2022;28:415-422.
    PubMed     Abstract available


  218. BENNETT A, Mamunes A, Kim M, Duley C, et al
    The Importance of Monitoring the Postpartum Period in Moderate to Severe Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:409-414.
    PubMed     Abstract available


  219. SINGH S, Qian AS, Nguyen NH, Ho SKM, et al
    Trends in U.S. Health Care Spending on Inflammatory Bowel Diseases, 1996-2016.
    Inflamm Bowel Dis. 2022;28:364-372.
    PubMed     Abstract available


  220. WHITE BA, Ramos GP, Kane S
    The Impact of Alcohol in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2022;28:466-473.
    PubMed     Abstract available


  221. YADAV A, Jena A, Arpitha K, Shah J, et al
    Colon Cancer in Ulcerative Colitis: A Mimicker of a Flare of Disease.
    Inflamm Bowel Dis. 2022 Mar 1. pii: 6540315. doi: 10.1093.
    PubMed    


  222. SHEEHAN JL, Jacob J, Berinstein EM, Greene-Higgs L, et al
    The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2022 Mar 1. pii: 6540317. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  223. MASUTA Y, Watanabe T, Minaga K, Kudo M, et al
    A Case of Ulcerative Colitis Relapse Characterized by Systemic Type I Interferon Responses after COVID-19 Vaccination.
    Inflamm Bowel Dis. 2022 Feb 26. pii: 6537472. doi: 10.1093.
    PubMed    


  224. LAMERS CR, de Roos NM, Heerink HH, van de Worp-Kalter LA, et al
    Lower Impact of Disease on Daily Life and Less Fatigue in Patients With Inflammatory Bowel Disease Following a Lifestyle Intervention.
    Inflamm Bowel Dis. 2022 Feb 25. pii: 6536898. doi: 10.1093.
    PubMed     Abstract available


  225. GROSEN A, Bellaguarda E, Liljeqvist-Soltic I, Mejlby Hansen M, et al
    Normal Sperm DNA Integrity in Patients With Inflammatory Bowel Disease on Ustekinumab Maintenance Therapy.
    Inflamm Bowel Dis. 2022 Feb 25. pii: 6536901. doi: 10.1093.
    PubMed    


  226. QUERA R, Nunez F P, Flores L
    SARS-CoV-2 Infection in the Follow-Up of a Population With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Feb 22. pii: 6534444. doi: 10.1093.
    PubMed    


  227. VALDES DELGADO T, Barranco Castro D, Arguelles Arias F
    Cap-Polyposis: A Cause of Treatment Failure in Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Feb 22. pii: 6534443. doi: 10.1093.
    PubMed    


  228. PHILIPPOU A, Birhanu B, Biello A, Keefer L, et al
    A Mixed-methods Assessment of the Impact of Insurance Issues on the Emotional and Physical Health of Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Feb 22. pii: 6534445. doi: 10.1093.
    PubMed     Abstract available


  229. KAYAL M, Kohler D, Plietz M, Khaitov S, et al
    Early Pouchitis Is Associated With Crohn's Disease-like Pouch Inflammation in Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Feb 21. pii: 6533541. doi: 10.1093.
    PubMed     Abstract available


  230. CAMPBELL JP, Teigen L, Manski S, Blumhof B, et al
    Sarcopenia Is More Prevalent Among Inflammatory Bowel Disease Patients Undergoing Surgery and Predicts Progression to Surgery Among Medically Treated Patients.
    Inflamm Bowel Dis. 2022 Feb 15. pii: 6528831. doi: 10.1093.
    PubMed     Abstract available


  231. BOYD T, Winter RW, Winter HS, Kissous-Hunt M, et al
    Provider Knowledge and Recommendations Regarding Ileoanal Pouch Surgery and Fertility in Women with Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Feb 15. pii: 6528828. doi: 10.1093.
    PubMed    


  232. BERBISA MAF, Nielsen KR, Ingham AC, Midjord J, et al
    Similar Gut Bacterial Composition Between Patients With Ulcerative Colitis and Healthy Controls in a High Incidence Population: A Cross-sectional Study of the Faroe Islands IBD Cohort.
    Inflamm Bowel Dis. 2022 Feb 9. pii: 6524838. doi: 10.1093.
    PubMed     Abstract available


  233. XIE Y, Li H, Zhou L, Tian F, et al
    A Case of Vedolizumab-induced Acute Allergic Reaction in a Patient With Refractory Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Feb 4. pii: 6522051. doi: 10.1093.
    PubMed    


  234. CHONGSRISAWAT V, Suratannon N, Chatchatee P, Ittiwut R, et al
    Novel CD55 Mutation Associated With Severe Small Bowel Ulceration Mimicking Inflammatory Bowel Disease in a Pair of Siblings.
    Inflamm Bowel Dis. 2022 Feb 4. pii: 6522222. doi: 10.1093.
    PubMed    


  235. THOMAS PWA, den Broeder N, Derikx M, Kievit W, et al
    Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study.
    Inflamm Bowel Dis. 2022 Feb 4. pii: 6522042. doi: 10.1093.
    PubMed     Abstract available


  236. BOKEMEYER B, Picker N, Wilke T, Rosin L, et al
    Inadequate Response, Treatment Patterns, Health Care Utilization, and Associated Costs in Patients With Ulcerative Colitis: Retrospective Cohort Study Based on German Claims Data.
    Inflamm Bowel Dis. 2022 Feb 4. pii: 6522041. doi: 10.1093.
    PubMed     Abstract available


  237. MOGHADAM P, Dumas M, Blum L, Gimenez I, et al
    Atypical Orofacial Granulomatosis Associated With Bowel Relapse in an Adult With Crohn's Disease Under Anti-TNF Therapy.
    Inflamm Bowel Dis. 2022;28:e25-e26.
    PubMed    


  238. JOHNSON S, Ko J, Halabi WJ, Stondell J, et al
    Fistula Healing Is Low After Fecal Diversion Surgery in Perianal Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:e17.
    PubMed    


  239. UENO A, Jijon HB, Peng R, Sparksman S, et al
    Association of Circulating Fibrocytes With Fibrostenotic Small Bowel Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:246-258.
    PubMed     Abstract available


  240. LEE SD, Singla A, Harper J, Barahimi M, et al
    Safety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:309-313.
    PubMed     Abstract available


  241. WIEGHARD NEK
    The Difficulty of Distal Crohn's Disease and the Utility of Diverting Stomas.
    Inflamm Bowel Dis. 2022;28:325-326.
    PubMed    


  242. ALRIC H, Amiot A, Kirchgesner J, Treton X, et al
    Vedolizumab Clinical Decision Support Tool Predicts Efficacy of Vedolizumab But Not Ustekinumab in Refractory Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:218-225.
    PubMed     Abstract available


  243. ADLER J, Lee GJ, Singer AAM
    Do Not Stop Anti-TNF Medications in Children With IBD When They Are Working.
    Inflamm Bowel Dis. 2022;28:322-324.
    PubMed    


  244. LIEFFERINCKX C, Bottieau J, Toubeau JF, Thomas D, et al
    Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2022;28:208-217.
    PubMed     Abstract available


    January 2022
  245. TANDON P, Lee E, Jogendran R, Kroeker KI, et al
    Breastfeeding Patterns in Mothers with Inflammatory Bowel Disease: A Pilot Prospective Longitudinal Study.
    Inflamm Bowel Dis. 2022 Jan 31. pii: 6517873. doi: 10.1093.
    PubMed     Abstract available


  246. GUZZO GL, Andrews JM, Weyrich LS
    The Neglected Gut Microbiome: Fungi, Protozoa, and Bacteriophages in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Jan 29. pii: 6517341. doi: 10.1093.
    PubMed     Abstract available


  247. HE ZX, Wang SL, Zhao SB, Li ZS, et al
    An Unusual Case of Hypernatremia in Patient With Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Jan 29. pii: 6517203. doi: 10.1093.
    PubMed    


  248. DA LUZ MOREIRA A, de Campos Lobato LF, de Lima Moreira JP, Luiz RR, et al
    Geosocial Features and Loss of Biodiversity Underlie Variable Rates of Inflammatory Bowel Disease in a Large Developing Country: A Population-Based Study.
    Inflamm Bowel Dis. 2022 Jan 28. pii: 6516702. doi: 10.1093.
    PubMed     Abstract available


  249. TARABAR D, El Jurdi K, Traboulsi C, Yvellez O, et al
    A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab.
    Inflamm Bowel Dis. 2022 Jan 25. pii: 6515101. doi: 10.1093.
    PubMed     Abstract available


  250. SEDANO R, Hogan M, McDonald C, Aswani-Omprakash T, et al
    Underrepresentation of Minorities and Lack of Race Reporting in Ulcerative Colitis Drug Development Clinical Trials.
    Inflamm Bowel Dis. 2022 Jan 25. pii: 6515239. doi: 10.1093.
    PubMed    


  251. LEBER A, Hontecillas R, Tubau-Juni N, Lichtiger S, et al
    WITHDRAWN: EFFICACY, SAFETY, AND TOLERABILITY OF OMILANCOR IN A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PATIENTS WITH ULCERATIVE COLITIS.
    Inflamm Bowel Dis. 2022;28.
    PubMed     Abstract available


  252. PETERSON AR, Hilley P, De Cruz P
    Combination Tofacitinib and Calcineurin Inhibitor in the Management of Treatment-Refractory Ulcerative Colitis May Be Effective, But Is It Necessary?
    Inflamm Bowel Dis. 2022 Jan 19. pii: 6511711. doi: 10.1093.
    PubMed    


  253. COWHERD E, Egberg MD, Kappelman MD, Zhang X, et al
    The Cumulative Incidence of Pouchitis in Pediatric Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Jan 18. pii: 6510907. doi: 10.1093.
    PubMed     Abstract available


  254. RUNDE J, Erondu A, Akiyama S, Traboulsi C, et al
    Outcomes of Ileoanal Pouch Anastomosis in Pediatric Ulcerative Colitis Are Worse in the Modern Era: A Time Trend Analysis Outcomes Following Ileal Pouch-Anal Anastomosis in Pediatric Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Jan 18. pii: 6510906. doi: 10.1093.
    PubMed     Abstract available


  255. MASSIMINO L, Spano S, Lamparelli LA, Fuggetta D, et al
    Tofacitinib Inhibits Leukocyte Trafficking Across the Intestinal Endothelial Barrier in a Specific Cohort of Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2022 Jan 15. pii: 6507842. doi: 10.1093.
    PubMed    


  256. KAPLAN GG, Underwood FE, Coward S, Agrawal M, et al
    The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis.
    Inflamm Bowel Dis. 2022 Jan 15. pii: 6507839. doi: 10.1093.
    PubMed     Abstract available


  257. LEWIS JD, Cross RK, Long M, Singh S, et al
    High Degree of Practice Variability in Colonic Dysplasia Surveillance for Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Jan 11. pii: 6503739. doi: 10.1093.
    PubMed    


  258. KIM SC
    Sudden-Onset Polyposis in Pediatric Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Jan 11. pii: 6503738. doi: 10.1093.
    PubMed    


  259. CUSHING KC, Du X, Chen Y, Stetson LC, et al
    Inflammatory Bowel Disease Risk Variants Are Associated with an Increased Risk of Skin Cancer.
    Inflamm Bowel Dis. 2022 Jan 8. pii: 6501204. doi: 10.1093.
    PubMed     Abstract available


  260. PARK J, Kang SJ, Yoon H, Park J, et al
    Histologic Evaluation Using the Robarts Histopathology Index in Patients With Ulcerative Colitis in Deep Remission and the Association of Histologic Remission With Risk of Relapse.
    Inflamm Bowel Dis. 2022 Jan 7. pii: 6500768. doi: 10.1093.
    PubMed     Abstract available


  261. PRENTICE R, Wright EK, Flanagan E, Ross AL, et al
    The Use of Fecal Calprotectin and Intestinal Ultrasound in the Evaluation and Management of Stricturing Crohn's Disease in Pregnancy.
    Inflamm Bowel Dis. 2022;28:e13-e16.
    PubMed    


  262. WEI Y, Yang W, Mei Q
    Detection of a Novel Antigen for Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:e5-e6.
    PubMed    


  263. WEN HZ, He ZH, Li PH, Zhao QF, et al
    Gluteal Sinus Presenting as the Initial Symptom in a Patient With Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:e11-e12.
    PubMed    


  264. NAZARI H, Naei VY, Tabasi AH, Badripour A, et al
    Advanced Regenerative Medicine Strategies for Treatment of Perianal Fistula in Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:133-142.
    PubMed     Abstract available


  265. DALAL RS, Gupta S, Goodrick H, Mitri J, et al
    Outcomes of Standard and Intensified Dosing of Ustekinumab for Chronic Pouch Disorders.
    Inflamm Bowel Dis. 2022;28:146-149.
    PubMed    


  266. BOUCHER G, Paradis A, Chabot-Roy G, Coderre L, et al
    Serum Analyte Profiles Associated With Crohn's Disease and Disease Location.
    Inflamm Bowel Dis. 2022;28:9-20.
    PubMed     Abstract available


  267. FAYE AS, Colombel JF
    Aging and IBD: A New Challenge for Clinicians and Researchers.
    Inflamm Bowel Dis. 2022;28:126-132.
    PubMed     Abstract available


  268. JOUSTRA V, Duijvestein M, Mookhoek A, Bemelman W, et al
    Natural History and Risk Stratification of Recurrent Crohn's Disease After Ileocolonic Resection: A Multicenter Retrospective Cohort Study.
    Inflamm Bowel Dis. 2022;28:1-8.
    PubMed     Abstract available


  269. TAPETE G, Bertani L, Pieraccini A, Lynch EN, et al
    Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry.
    Inflamm Bowel Dis. 2022;28:62-69.
    PubMed     Abstract available


  270. BERMEJO F, Jimenez L, Algaba A, Vela M, et al
    Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy.
    Inflamm Bowel Dis. 2022;28:41-47.
    PubMed     Abstract available


  271. LIU J, Ge X, Ouyang C, Wang D, et al
    Prevalence of Malnutrition, Its Risk Factors, and the Use of Nutrition Support in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Jan 4. pii: 6497520. doi: 10.1093.
    PubMed     Abstract available


  272. YANG H, Qian J
    Current status of cytomegalovirus colitis among patients with inflammatory bowel disease in China: A questionnaire-based multi-center study.
    Inflamm Bowel Dis. 2022 Jan 4. pii: 6497521. doi: 10.1093.
    PubMed     Abstract available


  273. ASHTON JJ, Boukas K, Stafford IS, Cheng G, et al
    Deleterious Genetic Variation Across the NOD Signaling Pathway Is Associated With Reduced NFKB Signaling Transcription and Upregulation of Alternative Inflammatory Transcripts in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Jan 3. pii: 6492639. doi: 10.1093.
    PubMed     Abstract available


  274. LARSEN MD, Norgard BM, Kjeldsen J
    Does Disease Activity After Induction Treatment With Biologics Predict Short-Term Outcome in Crohn's Disease and Ulcerative Colitis?
    Inflamm Bowel Dis. 2022 Jan 3. pii: 6491898. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  275. FANG L, Gao H, Gao X, Wu W, et al
    Risks of Cardiovascular Events in Patients with Inflammatory Bowel Disease in China: A Retrospective Multicenter Cohort Study.
    Inflamm Bowel Dis. 2021 Dec 30. pii: 6490203. doi: 10.1093.
    PubMed     Abstract available


  276. DULAI PS, Wong ECL, Reinisch W, Colombel JF, et al
    Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalimumab.
    Inflamm Bowel Dis. 2021 Dec 30. pii: 6490022. doi: 10.1093.
    PubMed     Abstract available


  277. MEISINGER C, Freuer D
    Causal Association Between Atopic Dermatitis and Inflammatory Bowel Disease: A 2-Sample Bidirectional Mendelian Randomization Study.
    Inflamm Bowel Dis. 2021 Dec 29. pii: 6488545. doi: 10.1093.
    PubMed     Abstract available


  278. SANDBORN WJ, Armuzzi A, Liguori G, Irving PM, et al
    Predictors of Sustained Response With Tofacitinib Therapy in Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Dec 27. pii: 6484790. doi: 10.1093.
    PubMed     Abstract available


  279. SHAH R, Elangovan A, Jordan DW, Katz J, et al
    10-Year Trend of Abdominal Magnetic Resonance Imaging Compared With Abdominal Computed Tomography Scans in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Dec 22. pii: 6479634. doi: 10.1093.
    PubMed     Abstract available


  280. SINGH AK, Sasani A, Dhamor D, Jena A, et al
    Surgical Management of Medical Refractory Acute Severe Ulcerative Colitis in Immune Thrombocytopenic Purpura: Killing Two Birds With One Stone.
    Inflamm Bowel Dis. 2021 Dec 20. pii: 6470737. doi: 10.1093.
    PubMed    


  281. ELIA JR, Beck KR
    The Importance of Physical Activity and Structured Exercise Distinction and Analysis-Response to "Physical Activity in Patients with Inflammatory Bowel Disease: A Narrative Review".
    Inflamm Bowel Dis. 2021 Dec 18. pii: 6469656. doi: 10.1093.
    PubMed    


  282. SHIMODAIRA Y, Watanabe K, Takahashi S, Koizumi S, et al
    Inflammatory Bowel Disease Triggered by BNT162b2 mRNA Vaccination for SARS-CoV-2.
    Inflamm Bowel Dis. 2021 Dec 18. pii: 6469651. doi: 10.1093.
    PubMed    


  283. HILL JE, Pena-Sanchez JN, Fernando C, Freitas AC, et al
    Composition and Stability of the Vaginal Microbiota of Pregnant Women With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Dec 17. pii: 6468817. doi: 10.1093.
    PubMed     Abstract available


  284. RAMAN M, Reimer RA, Ghosh S, Vallance J, et al
    The Importance of Physical Activity in Patients With Inflammatory Bowel Disease: A Narrative Review.
    Inflamm Bowel Dis. 2021 Dec 17. pii: 6468793. doi: 10.1093.
    PubMed    


  285. BAMIAS G, Pizarro TT, Cominelli F
    Immunological Regulation of Intestinal Fibrosis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Dec 14. pii: 6460699. doi: 10.1093.
    PubMed     Abstract available


  286. YANG L, Song X, Chen Y, Li Y, et al
    Treatment Decision-making in Chinese Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2021 Dec 11. pii: 6459488. doi: 10.1093.
    PubMed     Abstract available


  287. TSE CS, Siegel CA, Weaver SA, Oliver BJ, et al
    Health Confidence Is Associated With Disease Outcomes and Health Care Utilization in Inflammatory Bowel Disease: A Nationwide Cross-sectional Study.
    Inflamm Bowel Dis. 2021 Dec 10. pii: 6459204. doi: 10.1093.
    PubMed     Abstract available


  288. JENA A, Sachan A, Singh AK, Sharma V, et al
    Multifocal Pyoderma Gangrenosum at Presentation in a Patient With Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Dec 10. pii: 6459194. doi: 10.1093.
    PubMed    


  289. WAN Y, Yang L, Jiang S, Qian D, et al
    Excessive Apoptosis in Ulcerative Colitis: Crosstalk Between Apoptosis, ROS, ER Stress, and Intestinal Homeostasis.
    Inflamm Bowel Dis. 2021 Dec 6. pii: 6454294. doi: 10.1093.
    PubMed     Abstract available


  290. WEAVER KN, Zhang X, Dai X, Watkins R, et al
    Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID.
    Inflamm Bowel Dis. 2021 Dec 6. pii: 6454297. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  291. LEITE-GOMES E, Dias AM, Azevedo CM, Santos-Pereira B, et al
    Bringing to Light the Risk of Colorectal Cancer in Inflammatory Bowel Disease: Mucosal Glycosylation as a Key Player.
    Inflamm Bowel Dis. 2021 Nov 29. pii: 6446097. doi: 10.1093.
    PubMed     Abstract available


  292. SUN Y, Geng J, Chen X, Chen H, et al
    Association Between Inflammatory Bowel Disease and Dementia: A Longitudinal Cohort Study.
    Inflamm Bowel Dis. 2021 Nov 29. pii: 6445975. doi: 10.1093.
    PubMed     Abstract available


  293. CERNA K, Duricova D, Lukas M, Machkova N, et al
    Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study.
    Inflamm Bowel Dis. 2021 Nov 29. pii: 6445976. doi: 10.1093.
    PubMed     Abstract available


  294. ZHANG W, Scalori A, Fuh F, McBride J, et al
    Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease: Results from a Phase 1 Randomized Trial.
    Inflamm Bowel Dis. 2021 Nov 29. pii: 6446094. doi: 10.1093.
    PubMed     Abstract available


  295. BIRDA CL, Agarwal A, Goyal A
    A Rare Case of Hearing Loss in a Patient With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Nov 24. pii: 6438178. doi: 10.1093.
    PubMed    


  296. DESALERMOS A, Pimienta M, Kalligeros M, Shehadeh F, et al
    Safety of Immunizations for the Adult Patient With Inflammatory Bowel Disease-A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2021 Nov 24. pii: 6438176. doi: 10.1093.
    PubMed     Abstract available


  297. KJELDSEN S, Nielsen J, Mertz Norgard B, Kjeldsen J, et al
    Mesalazine in Inflammatory Bowel Disease and COVID-19: Hospitalization and Adverse In-Hospital Outcomes Based on Nationwide Data.
    Inflamm Bowel Dis. 2021 Nov 24. pii: 6438420. doi: 10.1093.
    PubMed     Abstract available


  298. WESTBERG K, Olen O, Soderling J, Bengtsson J, et al
    Primary Versus Staged Reconstruction and Risk of Surgical Failure in Patients With Ulcerative Colitis: a Nation-wide Cohort Study.
    Inflamm Bowel Dis. 2021 Nov 18. pii: 6430979. doi: 10.1093.
    PubMed     Abstract available


  299. SACHAN A, Singh AK
    Reply to Response to "Strongyloides stercoralis in Acute Severe Ulcerative Colitis-A Triggering Nuisance or an Opportunistic Bystander?" by Hokama et al.
    Inflamm Bowel Dis. 2021 Nov 15. pii: 6428578. doi: 10.1093.
    PubMed    


  300. PAPALIA I, Tjandra D, Quah S, Tan C, et al
    Colon Capsule Endoscopy in the Assessment of Mucosal Healing in Crohn's Disease.
    Inflamm Bowel Dis. 2021;27.
    PubMed     Abstract available


  301. LI Y, Chen J, Bolinger AA, Chen H, et al
    Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27.
    PubMed     Abstract available


  302. HONIG G, Larkin PB, Heller C, Hurtado-Lorenzo A, et al
    Research-Based Product Innovation to Address Critical Unmet Needs of Patients with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27.
    PubMed     Abstract available


  303. MOTTA JP, Deraison C, Le Grand S, Le Grand B, et al
    PAR-1 Antagonism to Promote Gut Mucosa Healing in Crohn's Disease Patients: A New Avenue for CVT120165.
    Inflamm Bowel Dis. 2021;27.
    PubMed     Abstract available


  304. YAU YY, Wasinger VC, Hirten RP, Chuang E, et al
    Current Trends in IBD-Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling System.
    Inflamm Bowel Dis. 2021;27.
    PubMed     Abstract available


  305. BUSQUETS D, Oliver L, Amoedo J, Ramio-Pujol S, et al
    RAID Prediction: Pilot Study of Fecal Microbial Signature With Capacity to Predict Response to Anti-TNF Treatment.
    Inflamm Bowel Dis. 2021;27.
    PubMed     Abstract available


  306. TANG J, Huang Z, Guo H, Chao K, et al
    Unexpected Liver Lesions in Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e161-e162.
    PubMed    


  307. BORGHINI R, Villanacci V, Oberti A, Caronna R, et al
    Long-term Effects of Teduglutide on Intestinal Mucosa in a Patient With Crohn's Disease and Short Bowel Syndrome: Clinical, Endoscopic and Histological Data Compared.
    Inflamm Bowel Dis. 2021;27:e152-e153.
    PubMed    


  308. DAR ANTAKI L, Volkov A, Ben-Horin S
    Cytomegalovirus Limited to the Rectum in an Immunosuppressed IBD Patient.
    Inflamm Bowel Dis. 2021;27:e154-e155.
    PubMed    


  309. ALLEGRETTI JR, Canakis A, McClure E, Marcus J, et al
    Infliximab De-escalation in Patients With Crohn's Disease in Clinical Remission Is Safe and Well-tolerated.
    Inflamm Bowel Dis. 2021;27:2031-2033.
    PubMed    


  310. AGUILAR D, Revilla L, Garrido-Trigo A, Panes J, et al
    Randomized Controlled Trial Substudy of Cell-specific Mechanisms of Janus Kinase 1 Inhibition With Upadacitinib in the Crohn's Disease Intestinal Mucosa: Analysis From the CELEST Study.
    Inflamm Bowel Dis. 2021;27:1999-2009.
    PubMed     Abstract available


  311. GHAFARI-SARAVI A, Rabizadeh S, Dubovsky A, Miller S, et al
    Technical Issues Are a Major Determinant of Patient Satisfaction in Virtual Visits for Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:2034-2037.
    PubMed    


  312. SOMINENI HK, Weitzner JH, Venkateswaran S, Dodd A, et al
    Site- and Taxa-Specific Disease-Associated Oral Microbial Structures Distinguish Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:1889-1900.
    PubMed     Abstract available


  313. MANZINI R, Schwarzfischer M, Atrott K, Laimbacher A, et al
    Combination of Vedolizumab With Tacrolimus Is More Efficient Than Vedolizumab Alone in the Treatment of Experimental Colitis.
    Inflamm Bowel Dis. 2021;27:1986-1998.
    PubMed     Abstract available


  314. WANG MH, Friton JJ, Raffals LE, Leighton JA, et al
    Novel Genetic Variant Predicts Surgical Recurrence Risk in Crohn's Disease Patients.
    Inflamm Bowel Dis. 2021;27:1968-1974.
    PubMed     Abstract available


  315. FLANAGAN E, Wright EK, Sparrow MP, Moore GT, et al
    A Single Educational Intervention Improves Pregnancy-Related Knowledge and Emotional Health Among Women With IBD Who Are Pregnant or Wish to Conceive.
    Inflamm Bowel Dis. 2021;27:1909-1918.
    PubMed     Abstract available


  316. KIM J, Yoon H, Kim N, Lee KM, et al
    Clinical Outcomes and Response Predictors of Vedolizumab Induction Treatment for Korean Patients With Inflammatory Bowel Diseases Who Failed Anti-TNF Therapy: A KASID Prospective Multicenter Cohort Study.
    Inflamm Bowel Dis. 2021;27:1931-1941.
    PubMed     Abstract available


  317. TRIPODI A, Spina L, Pisani LF, Padovan L, et al
    Anti-TNF-alpha Treatment Reduces the Baseline Procoagulant Imbalance of Patients With Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:1901-1908.
    PubMed     Abstract available


  318. HANZEL J, Dreesen E, Vermeire S, Lowenberg M, et al
    Corrigendum to: Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients with Crohn Disease: Posthoc Analysis of the LOVE-CD Study.
    Inflamm Bowel Dis. 2021 Nov 12. pii: 6426108. doi: 10.1093.
    PubMed    


  319. HOKAMA A, Fujita J
    Response to "Strongyloides stercoralis in Acute Severe Ulcerative Colitis-A Triggering Nuisance or an Opportunistic Bystander?"
    Inflamm Bowel Dis. 2021 Nov 12. pii: 6426022. doi: 10.1093.
    PubMed    


  320. LUTZ MK, Matthews LA, Tuan WJ, Caldera F, et al
    Did You Get My Message? Trends and Predictors of Inflammatory Bowel Disease Patient-to-Provider Electronic Messaging.
    Inflamm Bowel Dis. 2021 Nov 10. pii: 6425060. doi: 10.1093.
    PubMed    


  321. JAGT JZ, Struys EA, Ayada I, Bakkali A, et al
    Fecal Amino Acid Analysis in Newly Diagnosed Pediatric Inflammatory Bowel Disease: A Multicenter Case-Control Study.
    Inflamm Bowel Dis. 2021 Nov 10. pii: 6425057. doi: 10.1093.
    PubMed     Abstract available


  322. JENA A, Singh AK, Siddharda BV, Panda P, et al
    Mesalamine-Induced Perimyocarditis: Rare Adverse Event in a Patient With Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Nov 9. pii: 6425058. doi: 10.1093.
    PubMed    


  323. ZHANG S, Chen F, Wu J, Liu C, et al
    Regional Gray Matter Volume Changes in Brains of Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Nov 3. pii: 6420319. doi: 10.1093.
    PubMed     Abstract available


    October 2021
  324. TRIPATHI K, Godoy Brewer G, Thu Nguyen M, Singh Y, et al
    COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2021 Oct 27. pii: 6412576. doi: 10.1093.
    PubMed     Abstract available


  325. DAI C, Huang YH, Jiang M
    Successful Treatment of Ulcerative Colitis, Rectovaginal Fistula, and Skin Erythema Nodule With Adalimumab.
    Inflamm Bowel Dis. 2021 Oct 27. pii: 6412248. doi: 10.1093.
    PubMed    


  326. KING D, Chandan JS, Thomas T, Nirantharakumar K, et al
    The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021;27:1731-1739.
    PubMed     Abstract available


  327. SPENCER EA, Klang E, Dolinger M, Pittman N, et al
    Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients.
    Inflamm Bowel Dis. 2021;27:1862-1864.
    PubMed    


  328. CRISPINO F, Brinch D, Carrozza L, Cappello M, et al
    Acceptance of SARS-CoV-2 Vaccination Among a Cohort of IBD Patients From Southern Italy: A Cross-Sectional Survey.
    Inflamm Bowel Dis. 2021;27:e134-e135.
    PubMed    


  329. DALAL RS, Allegretti JR
    Fecal Microbiota Transplantation for Chronic Pouchitis: Promising Novel Therapeutic or Lost Cause?
    Inflamm Bowel Dis. 2021;27:1873-1875.
    PubMed    


  330. CEBALLOS D
    Predictors: How to Approach the Individualization of Treatment.
    Inflamm Bowel Dis. 2021;27:1876-1877.
    PubMed     Abstract available


  331. ARTHUR S, Palaniappan B, Afroz S, Sundaram U, et al
    Unique Regulation of Coupled NaCl Absorption by Inducible Nitric Oxide in a Spontaneous SAMP1/YitFc Mouse Model of Chronic Intestinal Inflammation.
    Inflamm Bowel Dis. 2021;27:1804-1812.
    PubMed     Abstract available


  332. KARJALAINEN EK, Renkonen-Sinisalo L, Satokari R, Mustonen H, et al
    Fecal Microbiota Transplantation in Chronic Pouchitis: A Randomized, Parallel, Double-Blinded Clinical Trial.
    Inflamm Bowel Dis. 2021;27:1766-1772.
    PubMed     Abstract available


  333. STULMAN MY, Asayag N, Focht G, Brufman I, et al
    Epidemiology of Inflammatory Bowel Diseases in Israel: A Nationwide Epi-Israeli IBD Research Nucleus Study.
    Inflamm Bowel Dis. 2021;27:1784-1794.
    PubMed     Abstract available


  334. CALDERA F, Balzora S, Hayney MS, Farraye FA, et al
    Ensuring High and Equitable COVID-19 Vaccine Uptake Among Patients With IBD.
    Inflamm Bowel Dis. 2021;27:1703-1705.
    PubMed     Abstract available


  335. KANG MJ, Kim HW, Park SB, Kang DH, et al
    A Case of Iliopsoas Abscess and Ileitis With Enterocutaneous Fistula Caused by a Toothpick Mimicking Small Bowel Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e121-e122.
    PubMed    


  336. VALDES DELGADO T, Arguelles Arias F, Gastearena Idoate MA
    Mixed Adenocarcinoma in a 44-Year-Old Male with Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e119-e120.
    PubMed    


  337. PATEL BM, Ramos Rivers C, Koutroumpakis F, Ahsan M, et al
    Ustekinumab-Induced Remission of Two Cases of Refractory Cutaneous Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e124.
    PubMed    


  338. LOU Y, Li Z
    Is It Crohn's Disease?
    Inflamm Bowel Dis. 2021;27:e116-e117.
    PubMed    


  339. ALAYO QA, Khatiwada A, Patel A, Zulfiqar M, et al
    Effectiveness and Safety of Combining Tofacitinib With a Biologic in Patients With Refractory Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:1698-1702.
    PubMed    


  340. ADLER J, Eder SJ, Gebremariam A, French KR, et al
    Development and Testing of a New Simplified Endoscopic Mucosal Assessment for Crohn's Disease: The SEMA-CD.
    Inflamm Bowel Dis. 2021;27:1585-1592.
    PubMed     Abstract available


  341. SINGH S, Heien HC, Sangaralingham L, Shah ND, et al
    Frailty and Risk of Serious Infections in Biologic-treated Patients With Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:1626-1633.
    PubMed     Abstract available


  342. KULKARNI C, Murag S, Cholankeril G, Fardeen T, et al
    Association of Anti-TNF Therapy With Increased Risk of Acute Cholangitis in Patients With Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2021;27:1602-1609.
    PubMed     Abstract available


  343. PATEL DB, van Deen WK, Almario CV, Khalil C, et al
    Assessing Patient Decision-Making on Biologic and Small-Molecule Therapies in Inflammatory Bowel Diseases: Insights From a Conjoint Analysis in the United States, Canada, and the United Kingdom.
    Inflamm Bowel Dis. 2021;27:1593-1601.
    PubMed     Abstract available


  344. PIPPIS EJ, Yacyshyn BR
    Clinical and Mechanistic Characteristics of Current JAK Inhibitors in IBD.
    Inflamm Bowel Dis. 2021;27:1674-1683.
    PubMed     Abstract available


  345. REENAERS C, de Roover A, Kohnen L, Nachury M, et al
    Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAID.
    Inflamm Bowel Dis. 2021 Oct 12. pii: 6391132. doi: 10.1093.
    PubMed     Abstract available


  346. ANNE SHAFER L, Shaffer S, Witt J, Nugent Z, et al
    IBD Disability Index Is Associated With Both Direct and Indirect Costs of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Oct 12. pii: 6390721. doi: 10.1093.
    PubMed     Abstract available


  347. YU N, Basnayake C, Connell W, Ding NS, et al
    Interventions to Improve Adherence to Preventive Care in Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2021 Oct 7. pii: 6383125. doi: 10.1093.
    PubMed     Abstract available


  348. HOWALDT S, Domenech E, Martinez N, Schmidt C, et al
    Corrigendum to: Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial.
    Inflamm Bowel Dis. 2021 Oct 6. pii: 6382159. doi: 10.1093.
    PubMed    


  349. RAMAN M, Rajagopalan V, Kaur S, Reimer RA, et al
    Physical Activity in Patients With Inflammatory Bowel Disease: A Narrative Review.
    Inflamm Bowel Dis. 2021 Oct 4. pii: 6380888. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  350. LEE KE, Lim F, Colombel JF, Hur C, et al
    Cost-effectiveness of Venous Thromboembolism Prophylaxis After Hospitalization in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 30. pii: 6378418. doi: 10.1093.
    PubMed     Abstract available


  351. GU X, Ke X, Shen M, Zhang M, et al
    Association Between Inflammatory Bowel Disease and Atopic Dermatitis: A Two-Sample Mendelian Randomization Study.
    Inflamm Bowel Dis. 2021 Sep 30. pii: 6378417. doi: 10.1093.
    PubMed    


  352. MICHEL HK, Boyle B, David J, Donegan A, et al
    The Pediatric Inflammatory Bowel Disease Medical Home: A Proposed Model.
    Inflamm Bowel Dis. 2021 Sep 25. pii: 6375326. doi: 10.1093.
    PubMed     Abstract available


  353. BOOTH A, Ford W, Brennan E, Magwood G, et al
    Towards Equitable Surgical Management of Inflammatory Bowel Disease: A Systematic Review of Disparities in Surgery for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 23. pii: 6374390. doi: 10.1093.
    PubMed     Abstract available


  354. MACISAAC MB, Julsgaard M, Flanagan E, Rowe S, et al
    Anti-TNFalpha Induction Therapy for Patients With Active Inflammatory Bowel Disease During Pregnancy: A Case Series.
    Inflamm Bowel Dis. 2021 Sep 18. pii: 6372251. doi: 10.1093.
    PubMed    


  355. LAWTON RC
    "The Tough Get Going": Understanding the Role of Resilience and a Multidimensional Conceptualization of Mental Health Among Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 17. pii: 6371841. doi: 10.1093.
    PubMed    


  356. DAILEY J, Kozhaya L, Dogan M, Hopkins D, et al
    Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 16. pii: 6371006. doi: 10.1093.
    PubMed     Abstract available


  357. OUAHED J
    Expanding Contributions of Monogenic Very Early Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 15. pii: 6370827. doi: 10.1093.
    PubMed     Abstract available


  358. BADER-MEUNIER B, Martins AL, Charbit-Henrion F, Meinzer U, et al
    Mevalonate Kinase Deficiency: A Cause of Severe Very-Early-Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 15. pii: 6370829. doi: 10.1093.
    PubMed     Abstract available


  359. VAHIDNEZHAD H, Youssefian L, Anbardar MH, Zeinali S, et al
    Very-Early-Onset Inflammatory Bowel Disease in a Patient With Junctional Epidermolysis Bullosa With a Homozygous Mutation in the alpha6 Integrin Gene (ITGA6).
    Inflamm Bowel Dis. 2021 Sep 15. pii: 6370826. doi: 10.1093.
    PubMed    


  360. MISHRA S, Kumar Singh A, Kopp C, Jena A, et al
    Tubercular Pleural Effusion in a Patient of Ulcerative Colitis Treated With Tofacitinib.
    Inflamm Bowel Dis. 2021 Sep 15. pii: 6370835. doi: 10.1093.
    PubMed    


  361. DE VOOGD F, Joshi H, Van Wassenaer E, Bots S, et al
    Intestinal Ultrasound to Evaluate Treatment Response During Pregnancy in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 15. pii: 6370832. doi: 10.1093.
    PubMed     Abstract available


  362. WU N, Li H, Zhang J, Huang W, et al
    Herpes Zoster in a Patient With Ulcerative Colitis After Vedolizumab Initiation-Causal Link or Only Temporal Coincidence?
    Inflamm Bowel Dis. 2021 Sep 4. pii: 6364140. doi: 10.1093.
    PubMed    


  363. HERMAN SM, Zaborniak K, Bernstein CN
    Insight into Inflammatory Bowel Disease Pathogenesis: Is the Answer Blowing in the Wind?
    Inflamm Bowel Dis. 2021 Sep 2. pii: 6362805. doi: 10.1093.
    PubMed     Abstract available


  364. BARNES EL, Nowell WB, Venkatachalam S, Dobes A, et al
    Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States.
    Inflamm Bowel Dis. 2021 Sep 2. pii: 6362806. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  365. PHILIPPOU A, Sehgal P, Ungaro RC, Wang K, et al
    High Levels of Psychological Resilience Are Associated With Decreased Anxiety in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Aug 27. pii: 6358608. doi: 10.1093.
    PubMed     Abstract available


  366. XERFAN EMS, Andersen ML, Tomimori J, Tufik S, et al
    Inflammatory Bowel Disease, Skin, and Sleep: An Overview of This Complex Interaction and Associated Issues.
    Inflamm Bowel Dis. 2021 Aug 27. pii: 6358561. doi: 10.1093.
    PubMed    


  367. RAFFALS LE, Saha S, Bewtra M, Norris C, et al
    The Development and Initial Findings of A Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD).
    Inflamm Bowel Dis. 2021 Aug 26. pii: 6358125. doi: 10.1093.
    PubMed     Abstract available


  368. MATSUNE Y, Yaguchi K, Saito S, Sakakibara H, et al
    Simultaneous Development of Ulcerative Colitis in the Sigmoidocolon Autotransplant Neovagina and the Residual Colorectum.
    Inflamm Bowel Dis. 2021 Aug 26. pii: 6358126. doi: 10.1093.
    PubMed    


  369. HASSAN-ZAHRAEE M, Ye Z, Xi L, Baniecki ML, et al
    Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Aug 24. pii: 6357022. doi: 10.1093.
    PubMed     Abstract available


  370. MALHI G, Tandon P, Perlmutter JW, Nguyen G, et al
    Risk Factors for Postpartum Disease Activity in Women With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2021 Aug 24. pii: 6357024. doi: 10.1093.
    PubMed     Abstract available


  371. XU Y, Tian Y, Li F, Wang Y, et al
    Circular RNA HECTD1 Mitigates Ulcerative Colitis by Promoting Enterocyte Autophagy Via miR-182-5p/HuR Axis.
    Inflamm Bowel Dis. 2021 Aug 24. pii: 6357021. doi: 10.1093.
    PubMed     Abstract available


  372. SABERZADEH-ARDESTANI B, Anushiravani A, Mansour-Ghanaei F, Fakheri H, et al
    Clinical Phenotype and Disease Course of Inflammatory Bowel Disease: A Comparison Between Sporadic and Familial Cases.
    Inflamm Bowel Dis. 2021 Aug 21. pii: 6356100. doi: 10.1093.
    PubMed     Abstract available


  373. BARNHOORN MC, Storm BN, de Boer NK, van der Voorn MMPJA, et al
    Azathioprine-induced Myelotoxicity After Switching Mesalazine Compound.
    Inflamm Bowel Dis. 2021;27:e114-e115.
    PubMed    


  374. KOCHAR B, Kalasapudi L, Ufere NN, Nipp RD, et al
    Systematic Review of Inclusion and Analysis of Older Adults in Randomized Controlled Trials of Medications Used to Treat Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:1541-1543.
    PubMed    


  375. WITTE M, Reiner J, Bannert K, Jaster R, et al
    Ileocolonic Healing After Extended Small Bowel Resection in Mice: NOD2 Deficiency Impairs Anastomotic Healing and Postoperative Outcome.
    Inflamm Bowel Dis. 2021;27:1503-1512.
    PubMed     Abstract available


  376. GEISMAN T, Chen L, Gray-Swain MR, Hiatt-Jensen D, et al
    Delivery Outcomes of Pregnant Patients With Inflammatory Bowel Diseases Compared With the General Population and With Women With Other Autoimmune Diseases at a Tertiary Care Center.
    Inflamm Bowel Dis. 2021;27:1418-1426.
    PubMed     Abstract available


  377. YANG Q, Chen L, Feng L, Liu C, et al
    Success of Cyclosporin and Tofacitinib Combination Therapy in a Patient With Severe Steroid-refractory Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Aug 16. pii: 6352953. doi: 10.1093.
    PubMed     Abstract available


  378. DEL SORDO R, Lupinacci G, Tanzi G, Bassotti G, et al
    Imatinib and Dasatinib-induced Ulcerative Colitis: Case Report.
    Inflamm Bowel Dis. 2021 Aug 10. pii: 6347487. doi: 10.1093.
    PubMed    


    July 2021
  379. UNGARO RC, Agrawal M, Brenner EJ, Zhang X, et al
    New Gastrointestinal Symptoms Are Common in Inflammatory Bowel Disease Patients With COVID-19: Data From an International Registry.
    Inflamm Bowel Dis. 2021 Jul 28. pii: 6329562. doi: 10.1093.
    PubMed    


  380. FALSEY A, Jo D, Sirak H, Moya D, et al
    Corticosteroids Can Be Used to Decrease Antidrug Antibodies in Pediatric Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jul 28. pii: 6329558. doi: 10.1093.
    PubMed    


  381. AXELRAD JE, Faye A, Slaughter JC, Harpaz N, et al
    Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia.
    Inflamm Bowel Dis. 2021 Jul 28. pii: 6329560. doi: 10.1093.
    PubMed     Abstract available


  382. MARKOVIC S, Ivanovski TK, Zogovic B, Kalaba A, et al
    The Effect of COVID-19 Resurgence on Morbidity and Mortality in Patients With IBD on Biologic Therapy.
    Inflamm Bowel Dis. 2021;27:e90.
    PubMed    


  383. WINTER MW, Levy LC
    Maybe Age Isn't Just a Number: Elderly-onset IBD Is a Demographic Deserving of Specific Considerations.
    Inflamm Bowel Dis. 2021;27:1363-1364.
    PubMed    


  384. PRIVITERA G, Pugliese D, Armuzzi A, Guidi L, et al
    Dual Targeted Therapy in Patient With Extensive Crohn's Disease: Different Response at Distinct Location.
    Inflamm Bowel Dis. 2021;27:e93-e94.
    PubMed    


  385. NEYAZI M, Bharadwaj SS, Bullers S, Varenyiova Z, et al
    Overexpression of Cancer-Associated Stem Cell Gene OLFM4 in the Colonic Epithelium of Patients With Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2021;27:1316-1327.
    PubMed     Abstract available


  386. SANTORU ML, Piras C, Murgia F, Leoni VP, et al
    Metabolic Alteration in Plasma and Biopsies From Patients With IBD.
    Inflamm Bowel Dis. 2021;27:1335-1345.
    PubMed     Abstract available


  387. MARRIE RA, Graff LA, Fisk JD, Patten SB, et al
    The Relationship Between Symptoms of Depression and Anxiety and Disease Activity in IBD Over Time.
    Inflamm Bowel Dis. 2021;27:1285-1293.
    PubMed     Abstract available


  388. ROZICH JJ, Luo J, Dulai PS, Collins AE, et al
    Disease- and Treatment-related Complications in Older Patients With Inflammatory Bowel Diseases: Comparison of Adult-onset vs Elderly-onset Disease.
    Inflamm Bowel Dis. 2021;27:1215-1223.
    PubMed     Abstract available


  389. DALAL RS, Njie C, Marcus J, Gupta S, et al
    Predictors of Ustekinumab Failure in Crohn's Disease After Dose Intensification.
    Inflamm Bowel Dis. 2021;27:1294-1301.
    PubMed     Abstract available


  390. CHIBA M, Ishii H, Sageshima M, Iwabuchi A, et al
    Appendiceal Orifice Inflammation in Severe Ulcerative Colitis and Its Resolution With Infliximab and Plant-based Diet as First-line Therapy.
    Inflamm Bowel Dis. 2021 Jul 22. pii: 6325475. doi: 10.1093.
    PubMed    


  391. SYAL G, Serrano M, Jain A, Cohen BL, et al
    Health Maintenance Consensus for Adults With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jul 19. pii: 6323888. doi: 10.1093.
    PubMed     Abstract available


  392. DAI C, Jiang M, Huang YH
    Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jul 14. pii: 6321215. doi: 10.1093.
    PubMed    


  393. COATES MD, Ba DM, Liu G, Dalessio S, et al
    Revisiting the Association Between Inflammatory Bowel Disease and Parkinson's Disease.
    Inflamm Bowel Dis. 2021 Jul 14. pii: 6321214. doi: 10.1093.
    PubMed     Abstract available


  394. SHIBUYA T, Nomura O, Nagahara A
    Safety and Efficacy of Ustekinumab for Ulcerative Colitis in a Liver Transplant Patient.
    Inflamm Bowel Dis. 2021 Jul 13. pii: 6320083. doi: 10.1093.
    PubMed    


  395. OJO BA, VanDussen KL, Rosen MJ
    The Promise of Patient-Derived Colon Organoids to Model Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Jul 12. pii: 6319488. doi: 10.1093.
    PubMed     Abstract available


  396. WEISSMAN S, Systrom HK, Aziz M, El-Dallal M, et al
    Colorectal Cancer Prevention in Inflammatory Bowel Disease: A Systematic Analysis of the Overall Quality of Guideline Recommendations.
    Inflamm Bowel Dis. 2021 Jul 10. pii: 6318812. doi: 10.1093.
    PubMed     Abstract available


  397. KHAN N, Pernes T, Weiss A, Trivedi C, et al
    Efficacy of Vedolizumab in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2021 Jul 10. pii: 6318811. doi: 10.1093.
    PubMed     Abstract available


  398. TSE CS, Singh S, Sandborn WJ
    A Framework for Clinical Trials of Neurobiological Interventions That Target the Gut-Brain Axis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jul 9. pii: 6318240. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  399. WALLDORF J, von Arnim U, Schmelz R, Riesner-Wehner A, et al
    SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.
    Inflamm Bowel Dis. 2021 Jun 28. pii: 6310707. doi: 10.1093.
    PubMed    


  400. CHOSHEN S, Turner D, Pratt LT, Precel R, et al
    Development and Validation of a Pediatric MRI-Based Perianal Crohn Disease (PEMPAC) Index-A Report from the ImageKids Study.
    Inflamm Bowel Dis. 2021 Jun 21. pii: 6307118. doi: 10.1093.
    PubMed     Abstract available


  401. TAFT TH, Quinton S, Jedel S, Simons M, et al
    Posttraumatic Stress in Patients With Inflammatory Bowel Disease: Prevalence and Relationships to Patient-Reported Outcomes.
    Inflamm Bowel Dis. 2021 Jun 17. pii: 6301664. doi: 10.1093.
    PubMed     Abstract available


  402. HANZEL J, Dreesen E, Vermeire S, Lowenberg M, et al
    Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients With Crohn Disease: Posthoc Analysis of the LOVE-CD Study.
    Inflamm Bowel Dis. 2021 Jun 17. pii: 6301858. doi: 10.1093.
    PubMed     Abstract available


  403. MUTLU EA
    IBD Development After Diverticulitis May Hold Clues to IBD Pathogenesis.
    Inflamm Bowel Dis. 2021;27:1172-1173.
    PubMed    


  404. KARJALAINEN EK, Renkonen-Sinisalo L, Satokari R, Mustonen H, et al
    Author's Reply: Fecal Microbiota Transplantation for Chronic Pouchitis: Promising Novel Therapeutic or Lost Cause?
    Inflamm Bowel Dis. 2021;27:e79-e80.
    PubMed    


  405. ALKAISSI LY, Winberg ME, Heil SDS, Haapaniemi S, et al
    Antagonism of Adherent Invasive E. coli LF82 With Human alpha-defensin 5 in the Follicle-associated Epithelium of Patients With Ileal Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:1116-1127.
    PubMed     Abstract available


  406. ZHOU LY, Lin SN, Rieder F, Chen MH, et al
    Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn's Disease: The Path From Bench to Bedside.
    Inflamm Bowel Dis. 2021;27:971-982.
    PubMed     Abstract available


  407. MAZZURANA L, Bonfiglio F, Forkel M, D'Amato M, et al
    Crohn's Disease Is Associated With Activation of Circulating Innate Lymphoid Cells.
    Inflamm Bowel Dis. 2021;27:1128-1138.
    PubMed     Abstract available


  408. BUISSON A, Mak WY, Andersen MJ, Lei D, et al
    Fecal Calprotectin Is Highly Effective to Detect Endoscopic Ulcerations in Crohn's Disease Regardless of Disease Location.
    Inflamm Bowel Dis. 2021;27:1008-1016.
    PubMed     Abstract available


  409. NGUYEN NH, Khera R, Dulai PS, Boland BS, et al
    National Estimates of Financial Hardship From Medical Bills and Cost-related Medication Nonadherence in Patients With Inflammatory Bowel Diseases in the United States.
    Inflamm Bowel Dis. 2021;27:1068-1078.
    PubMed     Abstract available


  410. RINAWI F, Ricciuto A, Church PC, Frost K, et al
    Association of Early Postinduction Adalimumab Exposure With Subsequent Clinical and Biomarker Remission in Children with Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:1079-1087.
    PubMed     Abstract available


  411. COLMAN RJ, Tsai YT, Jackson K, Boyle BM, et al
    Achieving Target Infliximab Drug Concentrations Improves Blood and Fecal Neutrophil Biomarkers in Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:1045-1051.
    PubMed     Abstract available


  412. HASAN B, Yim Y, Ur Rashid M, Khalid RA, et al
    Hyperbaric Oxygen Therapy in Chronic Inflammatory Conditions of the Pouch.
    Inflamm Bowel Dis. 2021;27:965-970.
    PubMed     Abstract available


  413. NGUYEN NH, Luo J, Ohno-Machado L, Sandborn WJ, et al
    Burden and Outcomes of Fragmentation of Care in Hospitalized Patients With Inflammatory Bowel Diseases: A Nationally Representative Cohort.
    Inflamm Bowel Dis. 2021;27:1026-1034.
    PubMed     Abstract available


  414. KUROWSKI JA, Milinovich A, Ji X, Bauman J, et al
    Differences in Biologic Utilization and Surgery Rates in Pediatric and Adult Crohn's Disease: Results From a Large Electronic Medical Record-derived Cohort.
    Inflamm Bowel Dis. 2021;27:1035-1044.
    PubMed     Abstract available


  415. QIN X
    High Fecal Proteolytic Activity That Precedes Ulcerative Colitis Likely Results From Impaired Inactivation of Pancreatic Proteases Rather Than Bacteria.
    Inflamm Bowel Dis. 2021 Jun 14. pii: 6298410. doi: 10.1093.
    PubMed    


  416. GALIPEAU HJ, Caminero A, Verdu EF
    Increased Bacterial Proteolytic Activity Detected Before Diagnosis of Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Jun 14. pii: 6298409. doi: 10.1093.
    PubMed    


  417. LAMAZZA A, Fiori E, Carati MV, Pronio AM, et al
    Self-Expandable Metal Stents for Refractory Complete Rectal Obstruction in Patients With Crohn Disease.
    Inflamm Bowel Dis. 2021 Jun 10. pii: 6295865. doi: 10.1093.
    PubMed    


  418. GONG L, Xiao J, Yi J, Xiao J, et al
    Immunomodulatory Effect of Serum Exosomes From Crohn Disease on Macrophages via Let-7b-5p/TLR4 Signaling.
    Inflamm Bowel Dis. 2021 Jun 9. pii: 6295437. doi: 10.1093.
    PubMed     Abstract available


  419. VANDE CASTEELE N, Leighton JA, Pasha SF, Cusimano F, et al
    Utilizing Deep Learning to Analyze Whole Slide Images of Colonic Biopsies for Associations Between Eosinophil Density and Clinicopathologic Features in Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Jun 9. pii: 6295436. doi: 10.1093.
    PubMed     Abstract available


  420. DAVID JG, Chute D, Reed B, Saeed S, et al
    Assessing the Prevalence of and Risk Factors for Disordered Eating Attitudes and Behaviors in Adolescents With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jun 9. pii: 6295433. doi: 10.1093.
    PubMed    


  421. JORDI SBU, Lang BM, Auschra B, von Kanel R, et al
    Depressive Symptoms Predict Clinical Recurrence of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jun 7. pii: 6294150. doi: 10.1093.
    PubMed     Abstract available


  422. DANESE S, Peyrin-Biroulet L
    Selective Tyrosine Kinase 2 Inhibition for Treatment of Inflammatory Bowel Disease: New Hope on the Rise.
    Inflamm Bowel Dis. 2021 Jun 5. pii: 6293782. doi: 10.1093.
    PubMed     Abstract available


  423. MIKAIL M, Wilson A
    Low Serum Tumor Necrosis Factor-alpha Antagonist Concentrations in Patients With Inflammatory Bowel Disease Who Achieve Healing From Pyoderma Gangrenosum.
    Inflamm Bowel Dis. 2021 Jun 5. pii: 6293784. doi: 10.1093.
    PubMed    


    May 2021
  424. LUI J, Ramos GP, Codipilly DC, Katzka D, et al
    The Use of Biologics for the Treatment of Esophageal Crohn Disease.
    Inflamm Bowel Dis. 2021 May 29. pii: 6288092. doi: 10.1093.
    PubMed    


  425. LI H, Shu H, Tian F
    Distinct Entity of Inflammatory Bowel Disease in Autoimmune Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2021 May 27. pii: 6285983. doi: 10.1093.
    PubMed    


  426. GAZOULI M, Dovrolis N, Bourdakou MM, Gizis M, et al
    Response to Anti-alpha4beta7 Blockade in Patients With Ulcerative Colitis Is Associated With Distinct Mucosal Gene Expression Profiles at Baseline.
    Inflamm Bowel Dis. 2021 May 27. pii: 6285911. doi: 10.1093.
    PubMed     Abstract available


  427. LIU JJ
    Disparity in the Care of black Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284055. doi: 10.1093.
    PubMed    


  428. SHAFFER SR, Erondu AI, Traboulsi C, Rai V, et al
    Achieving Histologic Normalization in Ulcerative Colitis Is Associated With a Reduced Risk of Subsequent Dysplasia.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284061. doi: 10.1093.
    PubMed     Abstract available


  429. PENA-SANCHEZ JN, Osei JA, Marques Santos JD, Jennings D, et al
    Increasing Prevalence and Stable Incidence Rates of Inflammatory Bowel Disease Among First Nations: Population-Based Evidence From a Western Canadian Province.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284047. doi: 10.1093.
    PubMed     Abstract available


  430. MORRIS GA, McNicol M, Boyle B, Donegan A, et al
    Increasing Biosimilar Utilization at a Pediatric Inflammatory Bowel Disease Center and Associated Cost Savings: Show Me the Money.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284046. doi: 10.1093.
    PubMed     Abstract available


  431. OLIVER BJ, Kennedy AM, van Deen WK, Weaver SA, et al
    Development of Balanced Whole System Value Measures for Inflammatory Bowel Disease Care in the IBD Qorus Collaborative Using a Modified Delphi Process.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284056. doi: 10.1093.
    PubMed     Abstract available


  432. IACUCCI M, Jeffery L, Acharjee A, Nardone OM, et al
    Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis-An Exploratory Study to Define Deep Remission.
    Inflamm Bowel Dis. 2021 May 21. pii: 6279651. doi: 10.1093.
    PubMed     Abstract available


  433. SACHAN A, Srivastava S, Shah J, Singh AK, et al
    Strongyloides Stercoralis in Acute Severe Ulcerative Colitis-A Triggering Nuisance or An Opportunistic Bystander?
    Inflamm Bowel Dis. 2021 May 21. pii: 6279668. doi: 10.1093.
    PubMed    


  434. HUSSAMEDDIN A, Sedano R, Ramsewak D, Driman D, et al
    Vedolizumab-Induced Endoscopic and Histologic Improvement in Gastric Menetrier's Disease in a Patient With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 May 21. pii: 6279703. doi: 10.1093.
    PubMed    


  435. HANZEL J, Jansen JM, Ter Steege RWF, Gecse KB, et al
    Multiple Switches From the Originator Infliximab to Biosimilars Is Effective and Safe in Inflammatory Bowel Disease: A Prospective Multicenter Cohort Study.
    Inflamm Bowel Dis. 2021 May 20. pii: 6278840. doi: 10.1093.
    PubMed     Abstract available


  436. VAN WASSENAER EA, Benninga MA, van Limbergen JL, D'Haens GR, et al
    Intestinal Ultrasound in Pediatric Inflammatory Bowel Disease: Promising, but Work in Progress.
    Inflamm Bowel Dis. 2021 May 20. pii: 6278841. doi: 10.1093.
    PubMed     Abstract available


  437. MCCURDY J, Siw KCK, Kandel R, Larrigan S, et al
    The Effectiveness and Safety of Hyperbaric Oxygen Therapy in Various Phenotypes of Inflammatory Bowel Disease: Systematic Review With Meta-analysis.
    Inflamm Bowel Dis. 2021 May 18. pii: 6277724. doi: 10.1093.
    PubMed     Abstract available


  438. CHEAH M, Wilson A, Solh Z, Khanna R, et al
    IgA-Mediated Warm Autoimmune Hemolytic Anemia as an Extraintestinal Manifestation in a Patient With Crohn Disease on Vedolizumab.
    Inflamm Bowel Dis. 2021 May 18. pii: 6277765. doi: 10.1093.
    PubMed    


  439. VERDE A, Grammegna A, Petrone E, Mastrominico A, et al
    Crohn-Like Colitis in a Young Boy With Hirschsprung Disease.
    Inflamm Bowel Dis. 2021 May 18. pii: 6277720. doi: 10.1093.
    PubMed    


  440. DOS SANTOS CHM, Koga GA
    Response to the Letter to the Editor: "Pyoderma Gangrenosum in An Ulcerative Colitis Pediatric Patient During Vedolizumab Therapy Successfully Treated With Oral Cyclosporine".
    Inflamm Bowel Dis. 2021 May 18. pii: 6277711. doi: 10.1093.
    PubMed    


  441. GRAZIANO F, Macaluso FS, Cassata N, Citrano M, et al
    Pyoderma Gangrenosum in An Ulcerative Colitis Pediatric Patient During Vedolizumab Therapy Successfully Treated With Oral Cyclosporine.
    Inflamm Bowel Dis. 2021 May 18. pii: 6277715. doi: 10.1093.
    PubMed    


  442. SQUIRE JD, Gonzalez-Estrada A, Caldera F, Farraye FA, et al
    COVID-19 Vaccination in Patients With Inflammatory Bowel Disease and History of Reaction to Injectable Therapies.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276957. doi: 10.1093.
    PubMed    


  443. DE FRIAS GOMES CG, de Almeida ASR, Mendes CCL, Ellul P, et al
    Histological Inflammation in the Endoscopically Uninflamed Mucosa is Associated With Worse Outcomes in Limited Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276940. doi: 10.1093.
    PubMed     Abstract available


  444. HILLEY P, Gilmore R, Srinivasan A, Choy M, et al
    Combined Targeted Treatment Using Biologic-Tofacitinib Co-Therapy in Chronic Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276958. doi: 10.1093.
    PubMed    


  445. FASOULAS K, Stergiou E, Soufleris K
    Ustekinumab for Crohn Disease With Severe Gastroduodenal Involvement.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276944. doi: 10.1093.
    PubMed    


  446. SANTELLA C, Bitton A, Filliter C, Bessissow T, et al
    Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276941. doi: 10.1093.
    PubMed     Abstract available



  447. Corrigendum to: Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276866. doi: 10.1093.
    PubMed    



  448. Erratum to: Timely Monitoring of Inflammation by Fecal Lactoferrin Rapidly Predicts Therapeutic Response in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276685. doi: 10.1093.
    PubMed    


  449. TAXONERA C, Alba C, Olivares D, Martin M, et al
    Innovation in IBD Care During the COVID-19 Pandemic: Results of a Cross-Sectional Survey on Patient-Reported Experience Measures.
    Inflamm Bowel Dis. 2021;27:864-869.
    PubMed     Abstract available


  450. GRAZIANO F, Buse M, Cassata N, Citrano M, et al
    Cerebral Venous Thrombosis in a Child With Very-Early-Onset IBD.
    Inflamm Bowel Dis. 2021;27:e71-e73.
    PubMed    


  451. SRINIVASAN A, van Langenberg D, De Cruz P
    Real-World Effectiveness of Ustekinumab Dose Intensification in Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e69.
    PubMed    


  452. AHMED W, Lukin DJ
    Finding a Needle in the Haystack? Defining the Role of Random Biopsies in IBD Dysplasia Surveillance.
    Inflamm Bowel Dis. 2021;27:787-790.
    PubMed    


  453. FIOCCHI C, Iliopoulos D
    IBD Systems Biology Is Here to Stay.
    Inflamm Bowel Dis. 2021;27:760-770.
    PubMed     Abstract available


  454. KUROWSKI JA, Bewtra M, Kodish E, Lashner B, et al
    Reducing the Spread of Internet Misinformation in IBD: Ethics and Responsibility.
    Inflamm Bowel Dis. 2021;27:960-962.
    PubMed    


  455. SUDHAKAR P, Verstockt B, Cremer J, Verstockt S, et al
    Understanding the Molecular Drivers of Disease Heterogeneity in Crohn's Disease Using Multi-omic Data Integration and Network Analysis.
    Inflamm Bowel Dis. 2021;27:870-886.
    PubMed     Abstract available


  456. GUPTA N, Lustig RH, Andrews H, Gokhale R, et al
    Clinical Variables Associated With Statural Growth in Pediatric Crohn's Disease Differ by Sex (The Growth Study).
    Inflamm Bowel Dis. 2021;27:751-759.
    PubMed     Abstract available


  457. WONG ECL, Marshall JK, Reinisch W, Narula N, et al
    Body Mass Index Does Not Impact Clinical Efficacy of Ustekinumab in Crohn's Disease: A Post Hoc Analysis of the IM-UNITI Trial.
    Inflamm Bowel Dis. 2021;27:848-854.
    PubMed     Abstract available


  458. LEVINE I, Malik F, Castillo G, Jaros B, et al
    Prevalence, Predictors, and Disease Activity of Sacroiliitis Among Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:809-815.
    PubMed     Abstract available


  459. VARBOBITIS I, Kokkotis G, Gizis M, Perlepe N, et al
    The IBD-F Patient Self-Assessment Scale Accurately Depicts the Level of Fatigue and Predicts a Negative Effect on the Quality of Life of Patients With IBD in Clinical Remission.
    Inflamm Bowel Dis. 2021;27:826-835.
    PubMed     Abstract available


  460. ATTAUABI M, Zhao M, Bendtsen F, Burisch J, et al
    Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:927-939.
    PubMed     Abstract available


  461. TAXONERA C, Olivares D, Alba C
    Tofacitinib in Acute Severe Ulcerative Colitis: Case Series and a Systematic Review-Authors' Reply.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275622. doi: 10.1093.
    PubMed    


  462. JAIRATH V, Guizzetti L, Baker KA, Williamson LA, et al
    Impact of COVID-19 on Inflammatory Bowel Disease Clinical Trial Recruitment: A Global Survey of Principal Investigators.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275617. doi: 10.1093.
    PubMed    


  463. HOWALDT S, Domenech E, Martinez N, Schmidt C, et al
    Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275616. doi: 10.1093.
    PubMed     Abstract available


  464. DALAL RS, Mitri J, Goodrick H, Allegretti JR, et al
    Real-World Comparison of Tofacitinib vs Ustekinumab Among Bio-Exposed Patients With Ulcerative Colitis: A Propensity Score Analysis.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275620. doi: 10.1093.
    PubMed    


  465. CLICK B, Merchea A, Colibaseanu DT, Regueiro M, et al
    Ileocolic Resection for Crohn Disease: The Influence of Different Surgical Techniques on Perioperative Outcomes, Recurrence Rates, and Endoscopic Surveillance.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275618. doi: 10.1093.
    PubMed     Abstract available


  466. JENA A, Mishra S, Sachan A, Singh H, et al
    Tofacitinib in Acute Severe Ulcerative Colitis: Case Series and a Systematic Review.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275623. doi: 10.1093.
    PubMed    


  467. MCCURDY JD, Reid J, Yanofsky R, Sinnathamby V, et al
    Fecal Diversion for Perianal Crohn Disease in the Era of Biologic Therapies: A Multicenter Study.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275627. doi: 10.1093.
    PubMed     Abstract available


  468. ALKHAYYAT M, Abureesh M, Almomani A, Abou Saleh M, et al
    Patients With Inflammatory Bowel Disease on Treatment Have Lower Rates of Celiac Disease.
    Inflamm Bowel Dis. 2021 May 14. pii: 6277368. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  469. XU F, Carlson SA, Wheaton AG, Greenlund KJ, et al
    COVID-19 Hospitalizations Among U.S. Medicare Beneficiaries With Inflammatory Bowel Disease, April 1 to July 31, 2020.
    Inflamm Bowel Dis. 2021 Apr 27. pii: 6255240. doi: 10.1093.
    PubMed    


  470. HYAMS JS, Brimacombe M, Haberman Y, Walters T, et al
    Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Apr 27. pii: 6255234. doi: 10.1093.
    PubMed     Abstract available


  471. RODRIGUEZ-LAGO I, Barreiro-de Acosta M
    Risk of Depression During the Natural History of Inflammatory Bowel Disease: The Phantom Menace.
    Inflamm Bowel Dis. 2021 Apr 26. pii: 6179794. doi: 10.1093.
    PubMed    



  472. Corrigendum to: Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2021 Apr 20. pii: 6240061. doi: 10.1093.
    PubMed    


  473. ELTABBAKH M, Abd Alaty W, Sakr MA, Sherief AF, et al
    Commenting on the Letter (Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic").
    Inflamm Bowel Dis. 2021;27:e66.
    PubMed    


  474. FOTEINOGIANNOPOULOU K, Mala A, Koutroubakis IE
    Extra-pleural Solitary Fibrous Tumor of the Pelvis in a Patient with Crohn's Disease Under Anti-TNF: A Case Report.
    Inflamm Bowel Dis. 2021;27:e55-e56.
    PubMed    


  475. MAGEN-RIMON R, Garah J, Rosen I, Shaoul R, et al
    Postsurgical Treatment in Pediatric Patients With Crohn's Disease: Physician Practice.
    Inflamm Bowel Dis. 2021;27:e51-e54.
    PubMed    


  476. OSTERMAN MT, VanDussen KL, Gordon IO, Davis EM, et al
    Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:677-685.
    PubMed     Abstract available


  477. PAULIDES E, Boukema I, van der Woude CJ, de Boer NKH, et al
    The Effect of Psychotherapy on Quality of Life in IBD Patients: A Systematic Review.
    Inflamm Bowel Dis. 2021;27:711-724.
    PubMed     Abstract available


  478. CANNATELLI R, Bazarova A, Zardo D, Nardone OM, et al
    Fecal Calprotectin Thresholds to Predict Endoscopic Remission Using Advanced Optical Enhancement Techniques and Histological Remission in IBD Patients.
    Inflamm Bowel Dis. 2021;27:647-654.
    PubMed     Abstract available


  479. GOREN G, Schwartz D, Friger M, Banai H, et al
    Randomized Controlled Trial of Cognitive-Behavioral and Mindfulness-Based Stress Reduction on the Quality of Life of Patients With Crohn Disease.
    Inflamm Bowel Dis. 2021 Apr 13. pii: 6224593. doi: 10.1093.
    PubMed     Abstract available


  480. ASONUMA K, Kobayashi T, Nakano M, Sagami S, et al
    Residual Short-Segment Distal Inflammation Has No Significant Impact on the Major Relapse of Extensive Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Apr 13. pii: 6224886. doi: 10.1093.
    PubMed     Abstract available


  481. SCARALLO L, Bolasco G, Barp J, Bianconi M, et al
    Anti-Tumor Necrosis Factor-Alpha Withdrawal in Children With Inflammatory Bowel Disease in Endoscopic and Histologic Remission.
    Inflamm Bowel Dis. 2021 Apr 9. pii: 6218764. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  482. HERNANDEZ J, Rouille E, Chocteau F, Allard M, et al
    Nonhypoalbuminemic Inflammatory Bowel Disease in Dogs as Disease Model.
    Inflamm Bowel Dis. 2021 Mar 30. pii: 6203397. doi: 10.1093.
    PubMed     Abstract available


  483. FANG J, Wang H, Xue Z, Cheng Y, et al
    PPARgamma: The Central Mucus Barrier Coordinator in Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Mar 27. pii: 6192824. doi: 10.1093.
    PubMed     Abstract available


  484. SHAH KP, Triana AJ, Gusdorf RE, McCoy AB, et al
    Demographic Factors Associated With Successful Telehealth Visits in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2021 Mar 26. pii: 6188947. doi: 10.1093.
    PubMed     Abstract available


  485. KLUSMANN B, Fleer J, Tovote KA, Weersma RK, et al
    Trajectories of Fatigue in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 26. pii: 6188945. doi: 10.1093.
    PubMed     Abstract available


  486. STIDHAM RW, Liu Y, Enchakalody B, Van T, et al
    The Use of Readily Available Longitudinal Data to Predict the Likelihood of Surgery in Crohn Disease.
    Inflamm Bowel Dis. 2021 Mar 26. pii: 6188946. doi: 10.1093.
    PubMed     Abstract available


  487. ZHANG T, Xu Y, Yao Y, Jin L, et al
    Randomized Controlled Trial: Perioperative Dexamethasone Reduces Excessive Postoperative Inflammatory Response and Ileus After Surgery for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 22. pii: 6179795. doi: 10.1093.
    PubMed     Abstract available


  488. SANDS BE, Long MD, Reinisch W, Panes J, et al
    Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Nonmelanoma Skin Cancer Rates From the Ulcerative Colitis Clinical Program.
    Inflamm Bowel Dis. 2021 Mar 20. pii: 6179119. doi: 10.1093.
    PubMed     Abstract available


  489. GARRIDO I, Lopes S, Macedo G
    Hit the Road JAK! The Role of New Oral Treatment in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 20. pii: 6179114. doi: 10.1093.
    PubMed     Abstract available


  490. KHORSHID M, AbdAllah M
    Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic".
    Inflamm Bowel Dis. 2021;27:e39.
    PubMed    


  491. WINTER RW, Ananthakrishnan A, Burke KE, Kochar B, et al
    Time to Negative SARS-CoV-2 PCR Should Not Delay Care Among Patients With Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:590-592.
    PubMed    


  492. AGRAWAL M, Brenner EJ, Zhang X, Modesto I, et al
    Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry.
    Inflamm Bowel Dis. 2021;27:585-589.
    PubMed    


  493. SANTANA GO, de Santana AC, Pfeilsticker VB
    Ileum Perforation in Crohn's Disease Patient During SARS-Cov-2 Infection.
    Inflamm Bowel Dis. 2021;27:e42.
    PubMed    


  494. SEDANO R, Dhaliwal I, Ramsewak D, Jairath V, et al
    Drug-induced Lupus Associated With Vedolizumab in a Patient with Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e47-e48.
    PubMed    


  495. FERNANDEZ ALVAREZ P, Maldonado Perez B, Castro Laria L, Arguelles-Arias F, et al
    Autoimmune Encephalitis During Treatment With Adalimumab: A Case Report in Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e40-e41.
    PubMed    


  496. ZHOU G, Wu H, Lin J, Lin R, et al
    TRIM21 Is Decreased in Colitis-associated Cancer and Negatively Regulates Epithelial Carcinogenesis.
    Inflamm Bowel Dis. 2021;27:458-468.
    PubMed     Abstract available


  497. DALAL RS, Palchaudhuri S, Snider CK, Lewis JD, et al
    Preadmission Cannabis Use Is Positively Correlated With Inpatient Opioid Dose Exposure in Hospitalized Patients With Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:500-506.
    PubMed     Abstract available


  498. COLMAN RJ, Portocarrero-Castillo A, Chona D, Hellmann J, et al
    Favorable Outcomes and Anti-TNF Durability After Addition of an Immunomodulator for Anti-Drug Antibodies in Pediatric IBD Patients.
    Inflamm Bowel Dis. 2021;27:507-515.
    PubMed     Abstract available


  499. PAUWELS RWM, Proietti E, van der Woude CJ, Oudijk L, et al
    Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 11. pii: 6168345. doi: 10.1093.
    PubMed     Abstract available


  500. BHAT S, Caldera F, Farraye FA
    Barriers to Administering Vaccines in Inflammatory Bowel Disease Centers.
    Inflamm Bowel Dis. 2021 Mar 11. pii: 6168341. doi: 10.1093.
    PubMed    


  501. ZAIATZ BITTENCOURT V, Jones F, Doherty G, Ryan EJ, et al
    Targeting Immune Cell Metabolism in the Treatment of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 10. pii: 6166277. doi: 10.1093.
    PubMed     Abstract available


  502. XIANG BJ, Huang YH, Dai C
    A Rare Autoinflammatory Syndrome Involving Acute Severe Ulcerative Colitis Combined With Iritis.
    Inflamm Bowel Dis. 2021 Mar 9. pii: 6163199. doi: 10.1093.
    PubMed    


  503. SCHMOYER CJ, Saidman J, Bohl JL, Bierly CL, et al
    The Pathogenesis and Clinical Management of Stricturing Crohn Disease.
    Inflamm Bowel Dis. 2021 Mar 9. pii: 6163204. doi: 10.1093.
    PubMed     Abstract available


  504. ANDERSON A, Cherfane C, Click B, Ramos-Rivers C, et al
    Monocytosis Is a Biomarker of Severity in Inflammatory Bowel Disease: Analysis of a 6-Year Prospective Natural History Registry.
    Inflamm Bowel Dis. 2021 Mar 9. pii: 6163208. doi: 10.1093.
    PubMed     Abstract available


  505. TAKAHASHI H, Ogawa M, Hoshina T, Kusuhara K, et al
    Multiple Nodules in the Kidney and Spleen Presenting as the Initial Manifestation of Crohn Disease.
    Inflamm Bowel Dis. 2021 Mar 9. pii: 6163180. doi: 10.1093.
    PubMed    


    February 2021
  506. VERSTOCKT S, Verstockt B, Machiels K, Vancamelbeke M, et al
    Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Feb 24. pii: 6148910. doi: 10.1093.
    PubMed     Abstract available


  507. NASSANI N, Sweiss N, Berry JT, Calhoun C, et al
    Leukocytoclastic Vasculitis in Cutaneous Crohn Disease in the Setting of COVID-19.
    Inflamm Bowel Dis. 2021 Feb 22. pii: 6146239. doi: 10.1093.
    PubMed    


  508. IMPERATORE N, Bennato R, D'Avino A, Lombardi G, et al
    SARS-CoV-2 as a Trigger for De Novo Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Feb 22. pii: 6146240. doi: 10.1093.
    PubMed    


  509. BORGHINI R, Vescovo M, Giordano C, Donato G, et al
    Onset of Suspected Ulcerative Colitis After Treatment With Tocilizumab in Patient With Celiac Disease and Juvenile Idiopathic Arthritis.
    Inflamm Bowel Dis. 2021 Feb 22. pii: 6146241. doi: 10.1093.
    PubMed    


  510. MORILLA I, Uzzan M, Cazals-Hatem D, Colnot N, et al
    Computational Learning of microRNA-Based Prediction of Pouchitis Outcome After Restorative Proctocolectomy in Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Feb 20. pii: 6145454. doi: 10.1093.
    PubMed     Abstract available


  511. CHIARELLA-REDFERN H, Lee S, Jubran B, Sharifi N, et al
    Suboptimal Vaccination Administration in Mothers With Inflammatory Bowel Disease and Their Biologic-Exposed Infants.
    Inflamm Bowel Dis. 2021 Feb 20. pii: 6145400. doi: 10.1093.
    PubMed     Abstract available


  512. MIRANDA-BAUTISTA J, Rodriguez-Feo JA, Puerto M, Lopez-Cauce B, et al
    Liver X Receptor Exerts Anti-Inflammatory Effects in Colonic Epithelial Cells via ABCA1 and Its Expression Is Decreased in Human and Experimental Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Feb 20. pii: 6145399. doi: 10.1093.
    PubMed     Abstract available


  513. CHUGH R, Proctor DD, Little A, Myung P, et al
    Cutaneous Vasculitis After Ustekinumab Induction in Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e30-e31.
    PubMed    


  514. SOFFER S, Dahan S, Maklakovski M, Dagan A, et al
    A Case of Aseptic Renal Abscesses Associated With IBD.
    Inflamm Bowel Dis. 2021;27:e28-e29.
    PubMed    


  515. LEON G, Hussey S, Walsh PT
    The Diverse Roles of the IL-36 Family in Gastrointestinal Inflammation and Resolution.
    Inflamm Bowel Dis. 2021;27:440-450.
    PubMed     Abstract available


  516. YANG Y, Zhang C, Jing D, He H, et al
    IRF5 Acts as a Potential Therapeutic Marker in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:407-417.
    PubMed     Abstract available


  517. STEINER CA, Rodansky ES, Johnson LA, Berinstein JA, et al
    AXL Is a Potential Target for the Treatment of Intestinal Fibrosis.
    Inflamm Bowel Dis. 2021;27:303-316.
    PubMed     Abstract available


  518. SCHARRER S, Lissner D, Primas C, Reinisch W, et al
    Passive Smoking Increases the Risk for Intestinal Surgeries in Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:379-385.
    PubMed     Abstract available


  519. BRENNER EJ, Long MD, Mann CM, Chen W, et al
    Responsiveness of the Patient-reported Outcomes Measurement Information System (PROMIS) Pediatric Measures to Changes in Disease Status and Quality of Life Among Children and Adolescents With Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:344-351.
    PubMed     Abstract available


  520. STONE JK, Shafer LA, Graff LA, Lix L, et al
    Utility of the MARS-5 in Assessing Medication Adherence in IBD.
    Inflamm Bowel Dis. 2021;27:317-324.
    PubMed     Abstract available


  521. TAXONERA C, Olivares D, Alba C
    Real-World Effectiveness and Safety of Tofacitinib in Patients With Ulcerative Colitis: Systematic Review With Meta-Analysis.
    Inflamm Bowel Dis. 2021 Feb 15. pii: 6136180. doi: 10.1093.
    PubMed     Abstract available


  522. PANES J, Lindsay JO, Teich N, Lindgren S, et al
    Colectomy Incidence Rates in Five-Year Data From the Observational Postmarketing Ulcerative Colitis Study of Originator Infliximab.
    Inflamm Bowel Dis. 2021 Feb 12. pii: 6134175. doi: 10.1093.
    PubMed     Abstract available


  523. DHARMASIRI S, Garrido-Martin EM, Harris RJ, Bateman AC, et al
    Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease.
    Inflamm Bowel Dis. 2021 Feb 11. pii: 6133075. doi: 10.1093.
    PubMed     Abstract available


  524. DALAL RS, Allegretti JR
    Ustekinumab Dose Optimization in Crohn Disease: One Size Does Not Fit All.
    Inflamm Bowel Dis. 2021 Feb 11. pii: 6133071. doi: 10.1093.
    PubMed    


  525. JUDGE C, Saeidi R, Sugrue K, Rabbitt L, et al
    Combining Therapies in Inflammatory Bowel Disease: End of the Line or a New Era?
    Inflamm Bowel Dis. 2021 Feb 5. pii: 6129139. doi: 10.1093.
    PubMed    


  526. MAHMMOD S, Schultheiss JPD, van Bodegraven AA, Dijkstra G, et al
    Outcome of Reverse Switching From CT-P13 to Originator Infliximab in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Feb 4. pii: 6128461. doi: 10.1093.
    PubMed     Abstract available


  527. BHURWAL A, Minacapelli CD, Patel A, Mutneja H, et al
    Evaluation of a U.S. National Cohort to Determine Utilization in Colectomy Rates for Ulcerative Colitis Among Ethnicities.
    Inflamm Bowel Dis. 2021 Feb 3. pii: 6127293. doi: 10.1093.
    PubMed     Abstract available


  528. DUBINSKY MC, Watanabe K, Molander P, Peyrin-Biroulet L, et al
    Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living With Ulcerative Colitis-Patients' and Physicians' View.
    Inflamm Bowel Dis. 2021 Feb 2. pii: 6126719. doi: 10.1093.
    PubMed     Abstract available


  529. BALDAN-MARTIN M, Chaparro M, Gisbert JP
    Tissue Proteomic Approaches to Understand the Pathogenesis of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Feb 2. pii: 6126723. doi: 10.1093.
    PubMed     Abstract available


  530. GARG R, Mohammed A, Singh A, Regueiro M, et al
    Trends and Outcomes of Acute Diverticulitis in Inflammatory Bowel Disease: A Propensity-matched National Study.
    Inflamm Bowel Dis. 2021 Feb 2. pii: 6126191. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  531. RUBIN DT, Sninsky C, Siegmund B, Sans M, et al
    International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey.
    Inflamm Bowel Dis. 2021 Jan 29. pii: 6123676. doi: 10.1093.
    PubMed     Abstract available


  532. ROBERTSON AR, Arnott ID
    How Can We Predict Who Would Benefit From a Small-Bowel Capsule Endoscopy When Staging Crohn Disease?
    Inflamm Bowel Dis. 2021 Jan 29. pii: 6123688. doi: 10.1093.
    PubMed    



  533. Corrigendum to: Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies.
    Inflamm Bowel Dis. 2021 Jan 29. pii: 6123652. doi: 10.1093.
    PubMed    


  534. SHAH J, Shah A, Hassman L, Gutierrez A, et al
    Ocular Manifestations of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121235. doi: 10.1093.
    PubMed     Abstract available


  535. CHUGH R, Kroner PT, Farraye FA, Ginsburg PM, et al
    Small-Bowel Lymphoma Mimicking Crohn Disease: A Case Series.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121236. doi: 10.1093.
    PubMed    


  536. DE SIRE R, Castiglione F, Picardi M, Mascolo M, et al
    Chemotherapy-Induced Remission of Steroid-Dependent Ulcerative Colitis Associated With Rectal Hodgkin Lymphoma.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121229. doi: 10.1093.
    PubMed    


  537. SORRENTINO D, Gray JM
    Timely Monitoring of Inflammation by Fecal Lactoferrin Rapidly Predicts Therapeutic Response in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121238. doi: 10.1093.
    PubMed     Abstract available


  538. SUZUKI K, Kakuta Y, Naito T, Takagawa T, et al
    Genetic Background of Mesalamine-induced Fever and Diarrhea in Japanese Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121230. doi: 10.1093.
    PubMed     Abstract available


  539. SEDANO R, Jairath V
    Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata.
    Inflamm Bowel Dis. 2021 Jan 23. pii: 6114619. doi: 10.1093.
    PubMed    


  540. SEDANO R, Jairath V
    High-Dose Rescue Tofacitinib Prevented Inpatient Colectomy in Acute Severe Ulcerative Colitis Refractory to Anti-TNF.
    Inflamm Bowel Dis. 2021 Jan 23. pii: 6114620. doi: 10.1093.
    PubMed    


  541. BURKE KE, Kochar B, Allegretti JR, Winter RW, et al
    Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:155-161.
    PubMed     Abstract available


  542. HASHASH JG, Jabak S, Francis FF, Regueiro M, et al
    Should We Be Screening for SARS-CoV-2 in IBD Patients Before Initiation of Biologic Therapy?
    Inflamm Bowel Dis. 2021;27:291-294.
    PubMed    


  543. LEE S, Clark-Snustad K
    Patient with Fistulizing Crohn's Disease with Nonresponse to Infliximab Subsequently Responds to Infliximab After Short-term Addition of Tacrolimus.
    Inflamm Bowel Dis. 2021;27:e20-e22.
    PubMed    


  544. DOS SANTOS CHM, Galindo ACA, da Silva BA, Dantas CR, et al
    Is There Really a Direct Relationship Between IBD and Anxiety/Depression, or Could Any Chronic Disease Have These Manifestations?
    Inflamm Bowel Dis. 2021;27:e18-e19.
    PubMed    


  545. NIGHOT P, Ma T
    Endocytosis of Intestinal Tight Junction Proteins: In Time and Space.
    Inflamm Bowel Dis. 2021;27:283-290.
    PubMed     Abstract available


  546. VAGIANOS K, Shafer LA, Witges K, Targownik LE, et al
    Association Between Change in Inflammatory Aspects of Diet and Change in IBD-related Inflammation and Symptoms Over 1 Year: The Manitoba Living With IBD Study.
    Inflamm Bowel Dis. 2021;27:190-202.
    PubMed     Abstract available


  547. SCHNELL A, Schwarz B, Wahlbuhl M, Allabauer I, et al
    Distribution and Cytokine Profile of Peripheral B Cell Subsets Is Perturbed in Pediatric IBD and Partially Restored During a Successful IFX Therapy.
    Inflamm Bowel Dis. 2021;27:224-235.
    PubMed     Abstract available


  548. DE CARVALHO LGF, Lima WG, Coelho LGV, Cardoso VN, et al
    Circulating Leptin Levels as a Potential Biomarker in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2021;27:169-181.
    PubMed     Abstract available


  549. MACALUSO FS, Fries W, Viola A, Centritto A, et al
    The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches.
    Inflamm Bowel Dis. 2021;27:182-189.
    PubMed     Abstract available


  550. BRAMUZZO M, Lionetti P, Miele E, Romano C, et al
    Phenotype and Natural History of Children With Coexistent Inflammatory Bowel Disease and Celiac Disease.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102415. doi: 10.1093.
    PubMed     Abstract available


  551. DI NARDO G, Quitadamo P, Quatrini M, Malfona F, et al
    Autoimmune Hemolitic Anemia in a Boy With Inactive Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102424. doi: 10.1093.
    PubMed    


  552. TA AD, Ollberding NJ, Karns R, Haberman Y, et al
    Association of Baseline Luminal Narrowing With Ileal Microbial Shifts and Gene Expression Programs and Subsequent Transmural Healing in Pediatric Crohn Disease.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102412. doi: 10.1093.
    PubMed     Abstract available


  553. ROY PALADHI U, Harb AH, Daniel SG, Dawwas GK, et al
    The Impact of Introducing Patient-Reported Inflammatory Bowel Disease Symptoms via Electronic Survey on Clinic Visit Length, Patient and Provider Satisfaction, and the Environment Microbiome.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102417. doi: 10.1093.
    PubMed    


  554. CHANDE N, Singh S, Narula N, Gordon M, et al
    Medical Management Following Surgical Therapy in Inflammatory Bowel Disease: Evidence from Cochrane Reviews.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102409. doi: 10.1093.
    PubMed    


  555. WEIMERS P, Ankersen DV, Lokkegaard ECL, Burisch J, et al
    Occurrence of Colorectal Cancer and the Influence of Medical Treatment in Patients With Inflammatory Bowel Disease: A Danish Nationwide Cohort Study, 1997 to 2015.
    Inflamm Bowel Dis. 2021 Jan 7. pii: 6067198. doi: 10.1093.
    PubMed     Abstract available


  556. LI N, Zhan S, Tian Z, Liu C, et al
    Alterations in Bile Acid Metabolism Associated With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 5. pii: 6063290. doi: 10.1093.
    PubMed     Abstract available


  557. REGENSBURGER D, Tenkerian C, Purzer V, Schmid B, et al
    Matricellular Protein SPARCL1 Regulates Blood Vessel Integrity and Antagonizes Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 4. pii: 6061405. doi: 10.1093.
    PubMed     Abstract available


  558. FOULON A, Pichois R, Sabbagh C, Fumery M, et al
    Bowel Endometriosis Mimicking Crohn Disease.
    Inflamm Bowel Dis. 2021 Jan 4. pii: 6061378. doi: 10.1093.
    PubMed    


  559. PUGLIESE D, Schepis T, Bove V, Privitera G, et al
    Morbidly Obese Patient With Ulcerative Colitis Treated With Endoscopic Gastroplasty: A Case Report.
    Inflamm Bowel Dis. 2021 Jan 4. pii: 6061374. doi: 10.1093.
    PubMed    


  560. KOCHHAR GS, Mohan BP, Khan SR, Chandan S, et al
    Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2021 Jan 4. pii: 6061413. doi: 10.1093.
    PubMed     Abstract available


  561. HONG S, Zaki TA, Main M, Hine AM, et al
    Comparative Evaluation of Conventional Stool Testing and Multiplex Molecular Panel in Outpatients With Relapse of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 2. pii: 6058972. doi: 10.1093.
    PubMed     Abstract available


  562. SCHARRER S, Primas C, Eichinger S, Tonko S, et al
    Inflammatory Bowel Disease and Risk of Major Bleeding During Anticoagulation for Venous Thromboembolism.
    Inflamm Bowel Dis. 2021 Jan 2. pii: 6058971. doi: 10.1093.
    PubMed     Abstract available


  563. BAR-GIL SHITRIT A, Ben-Horin S, Mishael T, Hoyda A, et al
    Detection of Ustekinumab in Breast Milk of Nursing Mothers With Crohn Disease.
    Inflamm Bowel Dis. 2021 Jan 2. pii: 6058989. doi: 10.1093.
    PubMed    


  564. JEON Y, Limketkai BN
    Implications of Dietary Impact on Hepatic Steatosis and IBD.
    Inflamm Bowel Dis. 2021;27:10-11.
    PubMed    


  565. PENRICE DD, Kamboj AK, Simonetto DA
    Infliximab-induced Liver Injury: A Common Link Between Crohn's Disease and Acute Liver Injury.
    Inflamm Bowel Dis. 2021;27:e7-e8.
    PubMed    


  566. REINISCH W, Gecse K, Halfvarson J, Irving PM, et al
    Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:106-122.
    PubMed     Abstract available


  567. RIPOLLES T, Poza J, Suarez Ferrer C, Martinez-Perez MJ, et al
    Evaluation of Crohn's Disease Activity: Development of an Ultrasound Score in a Multicenter Study.
    Inflamm Bowel Dis. 2021;27:145-154.
    PubMed     Abstract available


  568. OLAISEN M, Flatberg A, Granlund AVB, Royset ES, et al
    Bacterial Mucosa-associated Microbiome in Inflamed and Proximal Noninflamed Ileum of Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:12-24.
    PubMed     Abstract available


  569. CHICCO F, Magri S, Cingolani A, Paduano D, et al
    Multidimensional Impact of Mediterranean Diet on IBD Patients.
    Inflamm Bowel Dis. 2021;27:1-9.
    PubMed     Abstract available


  570. CALDERA F, Ley D, Hayney MS, Farraye FA, et al
    Optimizing Immunization Strategies in Patients with IBD.
    Inflamm Bowel Dis. 2021;27:123-133.
    PubMed     Abstract available


  571. ARVANITIS M, Hart LC, DeWalt DA, Diaz-Gonzalez de Ferris ME, et al
    Transition Readiness Not Associated With Measures of Health in Youth With IBD.
    Inflamm Bowel Dis. 2021;27:49-57.
    PubMed     Abstract available


  572. SZIGETHY E, Murphy SM, Ehrlich OG, Engel-Nitz NM, et al
    Mental Health Costs of Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:40-48.
    PubMed     Abstract available


  573. SEGAL JP, Askari A, Clark SK, Hart AL, et al
    The Incidence and Prevalence of Human Papilloma Virus-associated Cancers in IBD.
    Inflamm Bowel Dis. 2021;27:34-39.
    PubMed     Abstract available


  574. VASSEUR P, Dugelay E, Benamouzig R, Savoye G, et al
    Dietary Patterns, Ultra-processed Food, and the Risk of Inflammatory Bowel Diseases in the NutriNet-Sante Cohort.
    Inflamm Bowel Dis. 2021;27:65-73.
    PubMed     Abstract available


    December 2020
  575. HIRTEN RP, Danieletto M, Scheel R, Shervey M, et al
    Longitudinal Autonomic Nervous System Measures Correlate With Stress and Ulcerative Colitis Disease Activity and Predict Flare.
    Inflamm Bowel Dis. 2020 Dec 31. pii: 6056323. doi: 10.1093.
    PubMed     Abstract available


  576. HASOSAH M, Alqahtani A, Almehaidib A, Qurashi M, et al
    Congenital Chloride Diarrhea and Childhood Inflammatory Bowel Disease: A Multicenter Case Series.
    Inflamm Bowel Dis. 2020 Dec 30. pii: 6055672. doi: 10.1093.
    PubMed    


  577. BORREN NZ, Long MD, Sandler RS, Ananthakrishnan AN, et al
    Longitudinal Trajectory of Fatigue in Patients With Inflammatory Bowel Disease: A Prospective Study.
    Inflamm Bowel Dis. 2020 Dec 25. pii: 6047698. doi: 10.1093.
    PubMed     Abstract available


  578. QIN X
    More Epidemiological Studies Warranted to Determine the Cause of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Dec 17. pii: 6040645. doi: 10.1093.
    PubMed    


  579. CURTIS JR, Regueiro M, Yun H, Su C, et al
    Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data From the IBM MarketScan(R) Administrative Claims Database With Tofacitinib Trial Data.
    Inflamm Bowel Dis. 2020 Dec 16. pii: 6039005. doi: 10.1093.
    PubMed     Abstract available


  580. DWADASI S, Zafer M, Goens D, Paknikar R, et al
    Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Dec 15. pii: 6034840. doi: 10.1093.
    PubMed     Abstract available


  581. PARIAN AM, Limketkai BN, Chowdhury R, Brewer GG, et al
    Serrated Epithelial Change Is Associated With High Rates of Neoplasia in Ulcerative Colitis Patients: A Case-controlled Study and Systematic Review With Meta-analysis.
    Inflamm Bowel Dis. 2020 Dec 9. pii: 6028664. doi: 10.1093.
    PubMed     Abstract available


  582. MELO FJ, Pinto-Lopes P, Estevinho MM, Magro F, et al
    The Role of Dipeptidyl Peptidase 4 as a Therapeutic Target and Serum Biomarker in Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2020 Dec 9. pii: 6028655. doi: 10.1093.
    PubMed     Abstract available


  583. LEE C, Hong SN, Kim ER, Chang DK, et al
    Depletion of Intestinal Stem Cell Niche Factors Contributes to the Alteration of Epithelial Differentiation in SAMP1/YitFcsJ Mice With Crohn Disease-Like Ileitis.
    Inflamm Bowel Dis. 2020 Dec 4. pii: 6020062. doi: 10.1093.
    PubMed     Abstract available


  584. BERNSTEIN CN, Hitchon CA, Walld R, Bolton JM, et al
    The Impact of Psychiatric Comorbidity on Health Care Utilization in Inflammatory Bowel Disease: A Population-based Study.
    Inflamm Bowel Dis. 2020 Dec 4. pii: 6020061. doi: 10.1093.
    PubMed     Abstract available


  585. LEE SH, Walshe M, Oh EH, Hwang SW, et al
    Early Changes in Serum Albumin Predict Clinical and Endoscopic Outcomes in Patients With Ulcerative Colitis Starting Anti-TNF Treatment.
    Inflamm Bowel Dis. 2020 Dec 3. pii: 6017554. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  586. BATTAT R, Lukin D, Scherl EJ, Pola S, et al
    Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 30. pii: 6012174. doi: 10.1093.
    PubMed     Abstract available


  587. BAMBA S, Inatomi O, Takahashi K, Morita Y, et al
    Assessment of Body Composition From CT Images at the Level of the Third Lumbar Vertebra in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 25. pii: 6000807. doi: 10.1093.
    PubMed     Abstract available


  588. YOON H, Jangi S, Dulai PS, Boland BS, et al
    Histologic Remission Is Associated With Lower Risk of Treatment Failure in Patients With Crohn Disease in Endoscopic Remission.
    Inflamm Bowel Dis. 2020 Nov 25. pii: 6000793. doi: 10.1093.
    PubMed     Abstract available


  589. DIMOPOULOS C, Al-Bawardy B
    SARS-CoV-2 Infection and Dual-Biologic Therapy for Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:e153-e154.
    PubMed    


  590. UR RAHMAN A, Hussain I, Hasan B, Ur Rashid M, et al
    Association of Complicated Diverticulitis With Development of De Novo Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 18. pii: 5987626. doi: 10.1093.
    PubMed     Abstract available


  591. BROMS G, Friedman S, Kim SC, Wood ME, et al
    The Patterns of Use of Medications for Inflammatory Bowel Disease During Pregnancy in the US and Sweden Are Changing.
    Inflamm Bowel Dis. 2020 Nov 18. pii: 5987622. doi: 10.1093.
    PubMed     Abstract available


  592. GEEM D, Kugathasan S
    It Takes Two to Make It Right: Dual Biologic and Small Molecule Therapy for Treatment-Refractory Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 17. pii: 5984956. doi: 10.1093.
    PubMed    


  593. SEDANO R, Jairath V
    Tofacitinib Induced Long-term Clinical, Endoscopic, and Histological Remission as a 6th Line Agent in Medically Refractory Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Nov 17. pii: 5985000. doi: 10.1093.
    PubMed    


  594. ATTAUABI M, Burisch J, Seidelin JB
    Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study.
    Inflamm Bowel Dis. 2020 Nov 17. pii: 5985019. doi: 10.1093.
    PubMed    


  595. GONZALEZ-BERNARDO O, Riestra S, Vivas S, de Francisco R, et al
    Chromoendoscopy With Indigo Carmine vs Virtual Chromoendoscopy (iSCAN 1) for Neoplasia Screening in Patients With Inflammatory Bowel Disease: A Prospective Randomized Study.
    Inflamm Bowel Dis. 2020 Nov 10. pii: 5970332. doi: 10.1093.
    PubMed     Abstract available


  596. BRETON J, Witmer CM, Zhang Y, Downing M, et al
    Utilization of an Electronic Medical Record-integrated Dashboard Improves Identification and Treatment of Anemia and Iron Deficiency in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962204. doi: 10.1093.
    PubMed     Abstract available


  597. SHIRWAIKAR THOMAS A, Criss ZK, Shroyer NF, Abraham BP, et al
    Vitamin D Receptor Gene Single Nucleotide Polymorphisms and Association With Vitamin D Levels and Endoscopic Disease Activity in Inflammatory Bowel Disease Patients: A Pilot Study.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962201. doi: 10.1093.
    PubMed     Abstract available


  598. RAMOS GP, Dimopoulos C, McDonald NM, Janssens LP, et al
    The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962203. doi: 10.1093.
    PubMed     Abstract available


  599. SIVASAILAM B, Manski S, Wentz A, Cross RK, et al
    Presence of Obstructive Symptoms and Absence of Perianal Crohn Disease Is Predictive of Surgery After Endoscopic Balloon Dilation.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962193. doi: 10.1093.
    PubMed     Abstract available


  600. CORDES F, Lenker E, Weinhage T, Spille LJ, et al
    Impaired IFN-gamma-dependent STAT3 Activation Is Associated With Dysregulation of Regulatory and Inflammatory Signaling in Monocytes of Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962195. doi: 10.1093.
    PubMed     Abstract available


  601. SLEUTJES JAM, de Vries AC, van der Woude CJ, Roeters van Lennep JE, et al
    Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management.
    Inflamm Bowel Dis. 2020 Nov 6. pii: 5957728. doi: 10.1093.
    PubMed    


  602. HALLORAN BP, Jamil LH, Lo SK, Reeson M, et al
    Double-Balloon Endoscopy in Crohn Disease: A Tertiary Referral Center Experience.
    Inflamm Bowel Dis. 2020 Nov 6. pii: 5957726. doi: 10.1093.
    PubMed     Abstract available


  603. ALLEGRETTI JR, Kelly CR, Grinspan A, Mullish BH, et al
    Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection.
    Inflamm Bowel Dis. 2020 Nov 6. pii: 5957723. doi: 10.1093.
    PubMed     Abstract available


  604. BRUCKNER RS, Spalinger MR, Barnhoorn MC, Feakins R, et al
    Contribution of CD3+CD8- and CD3+CD8+ T Cells to TNF-alpha Overexpression in Crohn Disease-Associated Perianal Fistulas and Induction of Epithelial-Mesenchymal Transition in HT-29 Cells.
    Inflamm Bowel Dis. 2020 Nov 4. pii: 5955654. doi: 10.1093.
    PubMed     Abstract available


  605. BLOOMFELD RS, Bickston SJ
    Financial Toxicity in People With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 4. pii: 5955755. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  606. DOLINGER MT, Spencer EA, Lai J, Dunkin D, et al
    Dual Biologic and Small Molecule Therapy for the Treatment of Refractory Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Oct 30. pii: 5944028. doi: 10.1093.
    PubMed     Abstract available


  607. RUBIN DT, Griffith J, Zhang Q, Hepp Z, et al
    The Impact of Intestinal Complications on Health Care Costs Among Patients With Inflammatory Bowel Disease Treated With Anti-Tumor Necrosis Factor Therapies.
    Inflamm Bowel Dis. 2020 Oct 27. pii: 5940811. doi: 10.1093.
    PubMed     Abstract available


  608. BEHZAD C, Taheri H, Kashifard M
    Establishing Safe Out-of-Hospital Infusion Centers May Improve the Quality of Care in Patients With IBD During the COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020;26:e140.
    PubMed    


  609. HORRIGAN JM, Siegel CA, Tadros M
    Management of IBD Patients Who Are Unwilling or Unable to Receive Infusion Therapy During the COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020;26:e137.
    PubMed    


  610. ELTABBAKH MM, Shamkh MAA, Bassuny AN, Abd Alaty WH, et al
    Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020;26:1771-1778.
    PubMed    


  611. MATSUMOTO K, Urabe Y, Oka S, Inagaki K, et al
    Genomic Landscape of Early-stage Colorectal Neoplasia Developing From the Ulcerative Colitis Mucosa in the Japanese Population.
    Inflamm Bowel Dis. 2020 Oct 22. pii: 5934978. doi: 10.1093.
    PubMed     Abstract available


  612. FERREIRA-DUARTE M, Estevinho MM, Duarte-Araujo M, Magro F, et al
    Unraveling the Role of ACE2, the Binding Receptor for SARS-CoV-2, in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Oct 16. pii: 5925264. doi: 10.1093.
    PubMed     Abstract available


  613. RUBIN DT, Hart A, Panaccione R, Armuzzi A, et al
    Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians.
    Inflamm Bowel Dis. 2020 Oct 15. pii: 5924202. doi: 10.1093.
    PubMed     Abstract available


  614. KE J, He R, Hou X
    Reply to the Letter: Gut Microbiota-mediated Pleiotropic Effects of Fucose Can Improve Inflammatory Bowel Disease by Modulating Bile Acid Metabolism and Enhancing Propionate Production.
    Inflamm Bowel Dis. 2020 Oct 14. pii: 5923156. doi: 10.1093.
    PubMed    


  615. ALKHAYYAT M, Abureesh M, Gill A, Khoudari G, et al
    Lower Rates of Colorectal Cancer in Patients With Inflammatory Bowel Disease Using Anti-TNF Therapy.
    Inflamm Bowel Dis. 2020 Oct 14. pii: 5923165. doi: 10.1093.
    PubMed     Abstract available


  616. VANDE CASTEELE N, Feagan BG, Wolf DC, Pop A, et al
    Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Crohn Disease: A Theoretical Construct to Apply Pharmacokinetics and Guidelines to Clinical Practice.
    Inflamm Bowel Dis. 2020 Oct 14. pii: 5923164. doi: 10.1093.
    PubMed     Abstract available


  617. DE FREITAS LF, Feitosa MR, Feres O, Parra RS, et al
    Cutaneous Vasculitis Associated With Vedolizumab in Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Oct 13. pii: 5922392. doi: 10.1093.
    PubMed    


  618. CHEN G, Lissoos T, Dieyi C, Null KD, et al
    Development and Validation of an Inflammatory Bowel Disease Severity Index Using US Administrative Claims Data: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2020 Oct 12. pii: 5920980. doi: 10.1093.
    PubMed     Abstract available


  619. DOS SANTOS CHM, Koga GA
    The Challenge of Treating Pyoderma Gangrenosum in a Patient With Crohn Disease Based on Poor Scientific Evidence.
    Inflamm Bowel Dis. 2020 Oct 12. pii: 5920985. doi: 10.1093.
    PubMed    


  620. TRINDADE IA, Ferreira NB
    COVID-19 Pandemic's Effects on Disease and Psychological Outcomes of People With Inflammatory Bowel Disease in Portugal: A Preliminary Research.
    Inflamm Bowel Dis. 2020 Oct 12. pii: 5920974. doi: 10.1093.
    PubMed     Abstract available


  621. MARKOVIC S, Ivanovski TK, Zogovic B, Cvetkovic M, et al
    Biological Therapy for Inflammatory Bowel Disease During the COVID-19 Pandemic: Experiences From a Tertiary IBD Service.
    Inflamm Bowel Dis. 2020 Oct 12. pii: 5920986. doi: 10.1093.
    PubMed    


  622. FANTINI MC, Biancone L, Dragoni G, Bezzio C, et al
    Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey.
    Inflamm Bowel Dis. 2020 Oct 8. pii: 5919368. doi: 10.1093.
    PubMed    


  623. FANG X, Vazquez-Baeza Y, Elijah E, Vargas F, et al
    Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity.
    Inflamm Bowel Dis. 2020 Oct 7. pii: 5918916. doi: 10.1093.
    PubMed     Abstract available


    September 2020
  624. YU Q
    Slc26a3 (DRA) in the Gut: Expression, Function, Regulation, Role in Infectious Diarrhea and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Sep 29. pii: 5912727. doi: 10.1093.
    PubMed     Abstract available


  625. PEMMASANI G, Elgendy I, Mamas MA, Leighton JA, et al
    Epidemiology and Clinical Outcomes of Patients With Inflammatory Bowel Disease Presenting With Acute Coronary Syndrome.
    Inflamm Bowel Dis. 2020 Sep 26. pii: 5911943. doi: 10.1093.
    PubMed     Abstract available


  626. KUROWSKI JA, Achkar JP, Gupta R, Barbur I, et al
    Adipokine Resistin Levels at Time of Pediatric Crohn Disease Diagnosis Predict Escalation to Biologic Therapy.
    Inflamm Bowel Dis. 2020 Sep 26. pii: 5911945. doi: 10.1093.
    PubMed     Abstract available


  627. SINH P, Cross R
    Cardiovascular Risk Assessment and Impact of Medications on Cardiovascular Disease in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Sep 26. pii: 5911946. doi: 10.1093.
    PubMed     Abstract available


  628. NAVANEETHAN U, LehnerNoguera V
    Prolonged Duration of SARS-CoV-2 Viral Positivity in a Crohn's Disease Patient.
    Inflamm Bowel Dis. 2020;26:e124.
    PubMed    


    August 2020
  629. ZHANG Q, Chen D, Yang Y
    Incidence and Prevalence of Human Papilloma Virus-associated Cancers in IBD.
    Inflamm Bowel Dis. 2020;26:e101.
    PubMed    


    July 2020
  630. GOYAL A
    Clostridium Difficile and Increased Risk of Surgery in Crohn's Disease. Can Early Microbial Signatures Forecast Risk of Disease Progression?
    Inflamm Bowel Dis. 2020;26:1222-1224.
    PubMed    


    June 2020
  631. FLESHNER P
    Editorial on Hirten et al.
    Inflamm Bowel Dis. 2020;26:1059.
    PubMed    


  632. LIGHTNER AL
    Inflammation of the Ileal Anal Pouch: Do Biologics Really Change the Trajectory?
    Inflamm Bowel Dis. 2020;26:1087-1088.
    PubMed    


    May 2020
  633. XU F, Chen D, Yang Y
    Response to "Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease".
    Inflamm Bowel Dis. 2020;26:e47.
    PubMed    


  634. MCHENRY S, Ciorba MA, Deepak P
    Reply to the Letter to the Editor: Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:e46.
    PubMed    


  635. DAVIS BC
    Safety of Biologic Therapy in Liver Transplant Recipients: Case Closed?
    Inflamm Bowel Dis. 2020;26:960.
    PubMed    


  636. ZUNDLER S
    Utilization of Diagnostic Imaging and Ionizing Radiation Exposure-Has the Tide Already Turned?
    Inflamm Bowel Dis. 2020;26:907-908.
    PubMed     Abstract available


  637. LUKIN DJ
    Predictors of Perianal Fistula Relapse in Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:932-933.
    PubMed    


    April 2020
  638. KOUTROUMPAKIS F, Lodhi M, Ahsan M, Ramos Rivers C, et al
    The Impact of Cholecystectomy on Long-Term Disease Outcomes and Quality of Life in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2020 Apr 20. pii: 5822893. doi: 10.1093.
    PubMed     Abstract available


  639. TURNER D
    Antibiotics in Refractory IBD: Not Without Risks but Are the Alternatives Better? Response to Gilmore et al.
    Inflamm Bowel Dis. 2020;26:e42.
    PubMed    


  640. LIN S, Lin X, Li X, Chen M, et al
    Making Qualitative Intestinal Stricture Quantitative: Embracing Radiomics in IBD.
    Inflamm Bowel Dis. 2020;26:743-745.
    PubMed    


    March 2020
  641. LIMKETKAI BN, Gordon M, Mutlu EA, De Silva PS, et al
    Diet Therapy for Inflammatory Bowel Diseases: A Call to the Dining Table.
    Inflamm Bowel Dis. 2020;26:510-514.
    PubMed     Abstract available


  642. BRONSWIJK M, Moens A, Lenfant M, Tops S, et al
    Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center.
    Inflamm Bowel Dis. 2020;26:628-634.
    PubMed     Abstract available


    February 2020
  643. GARCIA MJ, Arminanzas C, Rivero M, Ramos M, et al
    Crohn's Disease and Immunosupressive Treatment: Hepatosplenic Lesions as an Atypical Case of Bartonella henselae.
    Inflamm Bowel Dis. 2020;26:e17-e18.
    PubMed    


  644. JUKEMA JB, Brandse JF, de Boer NKH
    Successful Treatment of Oral Crohn's Disease by Ustekinumab.
    Inflamm Bowel Dis. 2020;26:e19.
    PubMed    


  645. SAYOC-BECERRA A, Krishnan M, Fan S, Jimenez J, et al
    The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction.
    Inflamm Bowel Dis. 2020;26:407-422.
    PubMed     Abstract available


  646. JUN X, Ning C, Yang S, Zhe W, et al
    Alteration of Fungal Microbiota After 5-ASA Treatment in UC Patients.
    Inflamm Bowel Dis. 2020;26:380-390.
    PubMed     Abstract available


  647. CORDES F, Lenker E, Spille LJ, Weinhage T, et al
    Tofacitinib Reprograms Human Monocytes of IBD Patients and Healthy Controls Toward a More Regulatory Phenotype.
    Inflamm Bowel Dis. 2020;26:391-406.
    PubMed     Abstract available


  648. VASUDEVAN A, Ip F, Liew D, van Langenberg DR, et al
    The Cost-effectiveness of Initial Immunomodulators or Infliximab Using Modern Optimization Strategies for Crohn's Disease in the Biosimilar Era.
    Inflamm Bowel Dis. 2020;26:369-379.
    PubMed     Abstract available


  649. GAINES LS, Slaughter JC, Schwartz DA, Beaulieu DB, et al
    Does Reverse Causality Underlie the Temporal Relationship Between Depression and Crohn's Disease?
    Inflamm Bowel Dis. 2020;26:423-428.
    PubMed     Abstract available


    January 2020
  650. KARUPPUCHAMY T, Tyler CJ, Lundborg LR, Perez-Jeldres T, et al
    Sphingosine-1-Phosphate Lyase Inhibition Alters the S1P Gradient and Ameliorates Crohn's-Like Ileitis by Suppressing Thymocyte Maturation.
    Inflamm Bowel Dis. 2020;26:216-228.
    PubMed     Abstract available


  651. WANG X, Bootsma H, Kroese F, Dijkstra G, et al
    Senescent Stem and Transient Amplifying Cells in Crohn's Disease Intestine.
    Inflamm Bowel Dis. 2020;26:e8-e9.
    PubMed    


  652. LEWIS JD, Rutgeerts P, Feagan BG, D'haens G, et al
    Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:304-313.
    PubMed     Abstract available


  653. EGBERG MD, Galanko JA, Kappelman MD
    Weekend Surgical Admissions of Pediatric IBD Patients Have a Higher Risk of Complication in Hospitals Across the US.
    Inflamm Bowel Dis. 2020;26:254-260.
    PubMed     Abstract available


  654. LAURETI S, Gionchetti P, Cappelli A, Vittori L, et al
    Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection.
    Inflamm Bowel Dis. 2020;26:321-330.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: